<SEC-DOCUMENT>0000950170-24-067297.txt : 20240531
<SEC-HEADER>0000950170-24-067297.hdr.sgml : 20240531
<ACCEPTANCE-DATETIME>20240531160503
ACCESSION NUMBER:		0000950170-24-067297
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240531
FILED AS OF DATE:		20240531
DATE AS OF CHANGE:		20240531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oculis Holding AG
		CENTRAL INDEX KEY:			0001953530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41636
		FILM NUMBER:		241009591

	BUSINESS ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 7
		CITY:			ZUG
		STATE:			V8
		ZIP:			6300
		BUSINESS PHONE:		617-937-2423

	MAIL ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 7
		CITY:			ZUG
		STATE:			V8
		ZIP:			6300
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>6-k_agm_results_br.htm
<DESCRIPTION>6-K
<TEXT>
<html>
 <head>
  <title>6-K</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Washington, D.C. 20549</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid #000000;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM 6-K</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid #000000;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">REPORT OF FOREIGN ISSUER</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">PURSUANT TO RULE 13a-16 OR 15d-16</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">OF THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Month of May 2024</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Commission File No. 001-41636)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid #000000;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Oculis Holding AG</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Translation of registrant&#x2019;s name into English)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid #000000;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Bahnhofstrasse 7</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CH-6300</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Zug, Switzerland</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Address of registrant&#x2019;s principal executive office)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid #000000;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Form 20-F  &#9746;            Form 40-F  &#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #808080;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Press Release</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 30, 2024, Oculis Holding AG (the &#x201c;Registrant&#x201d;) published the results of its 2024 Annual General Meeting held at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, on May 29, 2024 at 3:30 p.m. CEST (the &#x201c;Meeting&#x201d;) and announced new appointments to its Board of Directors and Scientific Advisory Board, and its establishment of a CHF 50 million flexible loan facility (the &#x201c;Loan&#x201d;). The press release and the Registrant&#x2019;s latest Articles of Association, as amended by the shareholders at the Meeting, are furnished hereto as Exhibits 99.1 and 99.2, respectively.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Loan Facility</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 29, 2024, the Registrant entered into an agreement for a loan facility (the &#x201c;Loan Agreement&#x201d;) with Kreos Capital VII (UK) Limited (the &#x201c;Lender&#x201d;), which are funds and accounts managed by BlackRock, Inc. No amount was drawn at the signing of the Loan Agreement. The Loan Agreement is structured to provide the EUR equivalent of up to CHF 50.0 million in borrowing capacity (which may be increased to up to CHF 65.0 million), comprising tranches 1, 2 and 3, in the amounts of the EUR equivalents of CHF 20.0 million, CHF 20.0 million and CHF 10.0 million, respectively, as well as an additional loan of the EUR equivalent of up to CHF 15.0 million, which may be made available by the Lender to the Registrant if mutually agreed in writing by the Lender and the Registrant.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loan 1 will be available for drawdown from closing until May 29, 2025. Loans 2 and 3 will be available for drawdown prior to June 30, 2025 and December 31, 2025, respectively, in each case subject to satisfaction of certain pre-specified conditions.  The availability of any funds under a drawdown of Loans 1, Loan 2 or Loan 3 is conditional upon, together with other conditions, the Registrant having a debt-to-market cap ratio (where debt includes the amount of all amounts drawn down to date and the proposed drawdown) equal to or less than 15% at the time of each draw down.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Borrowings under the Loan will bear interest at a fixed rate (cash and PIK) of 9.95% per annum. The Loan will have an interest-only period of, in respect of Loans 1, 2 and 3, from the relevant drawdown date until the date falling 18 months, 12 months and 6 months, respectively, after the relevant drawdown date. Each of the interest-only periods can be extended by 6 months, if certain conditions are met. During the relevant interest-only period the Registrant will make monthly payments of interest only. Following the expiry of the relevant interest-only period, the loan will be repaid in 30 monthly payments of principal and interest.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Registrant may prepay all, but not part, of the term loan amounts at any time other than, unless the Lender agrees otherwise, by notifying the Lender in advance. The Loan is subject to mandatory prepayment in the event of a change of control or specified asset dispositions or licenses, subject to certain exceptions and thresholds. There are additional fees (including prepayment premia) payable to the Lender in the event the loan is prepaid either mandatorily or voluntarily.  The Lender received an upfront transaction fee of approximately CHF 200,000 and is eligible to receive an aggregate of approximately CHF 375,000 in additional transaction fees payable upon the Registrant&#x2019;s eligibility to receive and actual receipt of future drawdowns. On the date on which the Loan is prepaid or falls due for repayment in full, the Lender is eligible to receive an end of loan fee of, in relation to each of Loans 1, 2 and 3, 4.5% of the amount drawn down under the relevant loan.  The Loan contains customary affirmative and negative covenants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As additional consideration for the Loan, Kreos Capital VII Aggregator SCSp, an affiliate of the Lender (the &#x201c;Holder&#x201d;) received a warrant (the &#x201c;Warrant&#x201d;) to purchase up to 361,011 of the Registrant&#x2019;s ordinary shares, subject to vesting, at a price per ordinary share equal to $12.17, at signing and following any loan drawdowns, subject to adjustment (the &#x201c;Exercise Price&#x201d;). As of the signing date, the Warrant is exercisable for 43,321 ordinary shares and, following the drawdown of each of Loans 1, 2 and 3, the Warrant will become exercisable for additional amounts of ordinary shares ratably based on the amounts of Loans 1, 2 and 3 that are drawn. Each tranche of the Warrant will be exercisable for a period of up to seven years from the date of vesting and the Warrant will terminate at the earliest of (i) December 31, 2032, (ii) such earlier date on which the Warrant is no longer exercisable for any warrant shares in accordance with its terms and (iii) the acceptance by the shareholders of the Registrant of a third-party bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">offer for all outstanding shares of the Registrant (subject to any prior exercise by the Holder, if applicable). The Warrant also includes customary F-3 resale and piggyback registration rights and anti-dilution provisions.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Registrant intends to use the proceeds from the Loan Agreement for general corporate purposes.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing summaries of the Loan Agreement and the Warrant are not complete and are qualified in their entirety by reference to the full text of the Loan Agreement and the form of warrant agreement, respectively, copies of which the Registrant expects to file no later than with its Annual Report on Form 20-F for the fiscal year ending December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INCORPORATION BY REFERENCE</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This information contained in this Report on Form 6-K, including Exhibits 99.1 and 99.2, is hereby incorporated by reference into the Registrant&#x2019;s Registration Statements on Form S-8 (File No. 333-271938) and Form F-3 (File Nos. 333-278409 and 333-271063).</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXHIBIT INDEX</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.46%;"></td>
    <td style="width:1%;"></td>
    <td style="width:92.54%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:7.2pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</font></p></td>
   </tr>
   <tr style="height:7.2pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ocs-ex99_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release dated May 30, 2024</font></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ocs-ex99_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Articles of Association</font></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:45.9%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:6.68%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:43.1%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">OCULIS HOLDING AG</font></p></td>
   </tr>
   <tr style="height:12.25pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:middle;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:middle;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: May 31, 2024</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Sylvia Cheung</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sylvia Cheung</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ocs-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img187686630_0.jpg" alt="img187686630_0.jpg" style="width:298px;height:101px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Shareholders approved all agenda items and proposals of the Board of Directors</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of the Scientific Advisory Board</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Oculis established a CHF 50 million flexible loan facility with funds and accounts managed by BlackRock</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">ZUG, Switzerland, May 30, 2024</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> &#x2013; Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (&#x201c;Oculis&#x201d; or the &#x201c;Company&#x201d;), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the results from its 2024 Annual General Meeting held on May 29, 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST, including election of new members to its Board of Directors, as well as the recent appointment of two new members to its Scientific Advisory Board (SAB), and the establishment of a loan facility of up to CHF 50 million.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Annual General Meeting</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company&#x2019;s shareholders approved all agenda items, including the election of new members to its Board of Directors.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved the 2023 Annual Report including the 2023 Annual (Statutory) Financial Statements and the 2023 Consolidated Financial Statements.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders acknowledged that the Company made a loss of CHF 41,396,417.34 with respect to the financial year ended December 31, 2023, and resolved that the balance sheet loss shall be carried forward to the new accounts.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Members of the Board of Directors and the Executive Committee were granted discharge for their activities in 2023.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Anthony Rosenberg was re-elected as member and chairperson of the Board of Directors. Christina Ackermann, Lionel Carnot, Martijn Kleijwegt, Geraldine O&#x2019;Keeffe and Riad Sherif were re-elected as members of the Board of Directors. Robert K. Warner and Arshad M. Khanani were elected as members of the Board of Directors. Christina Ackermann and Lionel Carnot were re-elected and Robert K. Warner was elected as members of the Compensation Committee. PricewaterhouseCoopers SA (Pully) was re-elected as Statutory Auditors. PST Legal AG (Zug) was elected as Independent Proxy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved the compensation for the non-executive members of the Board of Directors:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">-</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Total maximum amount of fixed (non-performance-related) compensation for the non-executive members of the Board of Directors until the end of the Company&#x2019;s 2025 Annual General Meeting: USD 522,855.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">-</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Maximum value of equity or equity-based compensation for eight non-executive members of the Board of Directors until the end of the Company's 2025 Annual General Meeting: USD 1,215,000 (excluding employer social security and pension contributions).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved the compensation for members of the Executive Committee:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">-</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Total maximum amount of fixed (non-performance-related) compensation for four members of the Executive Committee for the calendar year 2025 payable in 2025: USD 2,478,240.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">-</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Total maximum amount of variable compensation for four members of the Executive Committee for the calendar year 2024 and payable in 2025 of USD 1,753,760.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">-</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Maximum value of equity-based compensation for four members of the Executive Committee until the end of the calendar year 2025: USD 12,768,000 (excluding employer social security and pension contributions).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders provided a non-binding advisory vote on the 2023 Compensation Report of the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved a capital band of 22'721'850 registered shares resulting in a capital band (taking into account the share issuance implemented on May 13, 2024) of CHF 464'437.00 to CHF 691'655.50 and the related amendment of the paragraphs 1 through 3 and paragraph 5 of article 3a of the articles of association in the form published on the website of the Company at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">https://investors.oculis.com/corporate-governance</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved a conditional share capital for bonds and similar debt instruments in the maximum amount of CHF 67'500.00 by the issuance of 6'750'000 registered shares and the related amendment of the paragraphs 1 and 2 of article 3b of the articles of association in the form published on the website of the Company  at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">https://investors.oculis.com/corporate-governance</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The shareholders approved a conditional share capital for employees and individuals of comparable positions in the maximum amount of CHF 95'663.02 by the issuance of 9'566'302 registered shares and the related amendment of article 3c, paragraph 1 of the articles of association in the form published on the website of the Company at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">https://investors.oculis.com/corporate-governance</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Riad Sherif, M.D., Chief Executive Officer of Oculis, commented: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;I would like to thank our team and all our investors and partners for their continuous support. I am honored to announce the addition of multiple industry and medical leaders to our Board of Directors and Scientific Advisory Board at this exciting time for the Company. We are confident that their tremendous knowledge, expertise, and track record will contribute to Oculis&#x2019; long-term success, as we</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">remain focused on progressing our innovative and diversified pipeline look ahead to the upcoming anticipated milestones this year including in Dry Eye Disease with licaminlimab (OCS-02) and in Acute Optic Neuritis with OCS-05, among others.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Appointments to Scientific Advisory Board</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">On May 29, 2024, the Company appointed Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D.as members of its Scientific Advisory Board.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Loan Facility</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">On May 29, 2024, Oculis established a flexible loan facility with funds and accounts managed by BlackRock, which provides the Company access to CHF 50 million. No amounts were drawn at signing. The relevant agreements related to the loan facility will be filed with the U.S. Securities and Exchange Commission no later than with its Annual Report on Form 20-F for the fiscal year ending December 31, 2024 and will be available on Oculis&#x2019; website at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">https://investors.oculis.com/sec-filings</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">-ENDS-</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">About newly elected members of the Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Robert K. Warner was a member of the Alcon Executive Leadership Team for over 10 years and led the Alcon transition from Nestle to Novartis majority ownership. While at Alcon, he served as President and General Manager of Alcon Vision Care Franchise Alcon Laboratories (NYSE:ALC) and as President, U.S. and Canada, after serving in other leadership positions of increasing responsibilities for several years.</font><font style="color:#333333;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">He currently serves on the board of two public companies. At INARI Medical (NASDAQ: NARI), Mr. Warner serves on its audit committee, and at RXSight, Inc. (NASDAQ: RXST), he serves as chair of the nominating and corporate governance committee and as a member of the compensation committee. In addition, Mr. Warner serves on the board of two private medical device companies, i-Lumen Scientific, where he is also a member of the compensation committee, and EyeYon Medical, where he also serves as Chairman of the board. Mr. Warner holds a B.S. in Chemistry from Pace University and an MBA from Rutgers University.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Arshad M. Khanani, M.D., M.A., FASRS founded the clinical research section at Sierra EyeAssociates, and currently serves as its Managing Partner, Director of Clinical Research, and Director of  Fellowship. He has been a principal investigator for more than 120 clinical trials and a top enroller in the United States for multiple Phase 1-3 trials. He is also a Clinical Professor at the University of Nevada, Reno School of Medicine. Dr. Khanani is an elected member of the Retina Society, Macula Society and has received numerous awards of distinction. He has received the Senior Honor Award from the American Society of Retina Specialists (ASRS) and was also awarded the prestigious ASRS Presidents&#x2019; Young Investigator Award in 2021. Dr. Khanani completed his Fellowship in Vitreo-Retinal Diseases and Surgery at the UT Southwestern Medical Center, his Chief Resident in Ophthalmology and his Ophthalmology Residency Program at Texas Tech University Health Sciences Center, where he also received his Doctor of Medicine (M.D.) degree. Dr. Khanani completed an</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Internship in Internal Medicine at Baylor College and received a Master and Bachelor of Arts (M.A. and B.A.) in Chemistry from Washington University in St. Louis.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">About newly appointed members of the Scientific Advisory Board</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Frank G. Holz, F.E.B.O., F.A.R.V.O. is Professor and Chairman of the Department of Ophthalmology at the University of Bonn, Germany. His main research interests include the pathogenesis, biomarkers and new therapies for macular and retinal diseases including age-related macular degeneration, retinal vascular diseases and macular telangiectasia. His major clinical interest is medical and surgical retina. He has a keen interest in innovative retinal imaging technologies and image analysis strategies. He was a scholar of the German National Academic Foundation (Studienstiftung des deutschen Volkes), trained at the University of Heidelberg, Germany, and the University of Chicago/Pritzker School of Medicine, and passed a fellowhip at Moorfields Eye Hospital, London, with Prof. Alan C. Bird. Professor Holz has been a cofounder of the Priority Program AMD of the German Research Council (DFG) and founded the GRADE Reading Center Bonn to perform digital image analysis in multicentre clinical natural history and interventional trials, and is project lead of the Macustar study funded by the IMI2 EU program. He is a Board Member of the German Ophthalmological Society (DOG), and EURETINA, Member of the Club Jules Gonin, the European Academy of Ophthalmology (EAO), the Macula Society, the Gass Club, Editor-in-Chief of Der Ophthalmologe, and serves a reviewer for many peer reviewed journals. He has received numerous awards including the Pro Retina Macular Degeneration Research Award, the Leonhard-Klein Award for Ocular Surgery, the Alcon Research Institute (ARI) Award, the Senior Achievement Award of the AAO and the Jules Gonin Award. He published more than 500 articles in peer reviewed journals and is editor of several books on retinal diseases. Professor Holz completed his Residency Program in Ophthalmology at the University of Heidelberg, Germany where he also received his Doctor of Medicine (M.D.) degree. Later on, he completed a Research and Clinical Fellowship in Medical Retina at the Institute of Ophthalmology, Moorfields Eye Hospital, in London, England.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Baruch D. Kuppermann, M.D., Ph.D., is the Steinert Endowed Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine, and serves as the co-director of the Center for Translational Vision Research at UC Irvine, which is focused on developing new treatments for blinding retinal conditions. He also holds a joint appointment with the Department of Biomedical Engineering at UC Irvine. He has published over 300 peer-reviewed articles in the medical literature, and over 100 book chapters. His laboratory focuses on assessing the toxicity of drugs on retinal cells in culture, including various vital stains, steroids, and anti-VEGF compounds, as well as studying the role of mitochondrial genetics in the development of retinal diseases such as age related macular degeneration. He is also strongly involved in clinical research, having served as Principal Investigator in many trials evaluating new drugs and technologies for the treatment of age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, retinitis pigmentosa, and other diseases of the posterior segment. He is a peer reviewer for the American Journal of Ophthalmology, Archives of Ophthalmology, Investigative Ophthalmology and Visual Science, Journal of Infectious Diseases, Lancet, Ophthalmology, Retina, and Survey of Ophthalmology. He serves on the Editorial Board of the journal Retina, as well as the Brazilian Archives of Ophthalmology, Brazilian Journal of Ophthalmology, and Retina Today. Dr. Kuppermann also serves on the Board of Directors of the Armenian</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">EyeCare Project. He received his Ph.D. in neuroscience at the California Institute of Technology, and his medical degress at the University of Miami. He completed his residency at University of Southern California Doheny Eye Institute and his fellowships in Retina at both St. Joseph&#x2019;s Medical Center in Baltimore under Drs Ronald Michels and Bert Glaser, and at the University of California, San Diego.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">About Oculis</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis&#x2019; highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02, a topical biologic anti-TNF&#x3b1; eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis&#x2019; goal is to improve the health and quality of life of patients worldwide. The company is led by an experienced management team with a successful track record and is supported by leading international healthcare investors.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">For more information, please visit: </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">www.oculis.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Oculis Contacts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Ms. Sylvia Cheung, CFO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#467886;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">sylvia.cheung@oculis.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Investor &amp; Media Relations</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">LifeSci Advisors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Corey Davis, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#467886;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">cdavis@lifesciadvisors.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">1-212-915-2577</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Cautionary Statement Regarding Forward Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This press release contains forward-looking statements and information. For example, expected future milestones and catalysts; anticipated clinical milestones, including in Dry Eye Disease with licaminlimab (OCS-02) and in Acute Optic Neuritis with OCS-05; the initiation, timing, progress and results of Oculis&#x2019; clinical and preclinical studies; Oculis&#x2019; research and development programs, regulatory and business strategy, future development plans, and management; Oculis&#x2019; ability to advance product candidates into, and successfully complete, clinical trials; and the timing or likelihood of regulatory filings and approvals, are forward-looking. All forward-looking statements are based on estimates and assumptions that, while considered reasonable by Oculis and its management, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond Oculis&#x2019; control. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, assurance, prediction or definitive statement of a fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. All forward-looking</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.49in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">statements are subject to risks, uncertainties and other factors that may cause actual results to differ materially from those that we expected and/or those expressed or implied by such forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Oculis, including those set forth in the Risk Factors section of Oculis&#x2019; annual report on Form 20-F and any other documents filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Copies of these documents are available on the SEC&#x2019;s website, www.sec.gov. Oculis undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ocs-ex99_2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html>
 <head>
  <title>EX-99.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">1</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Articles of association<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">of</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oculis Holding AG <br>(Oculis Holding SA)<br>(Oculis Holding Ltd)</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">with registered office in</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zug</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(Translation; in case of controversy the German text shall prevail)</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">STATUTEN<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">der</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oculis Holding AG <br>(Oculis Holding SA)<br>(Oculis Holding Ltd)</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">mit Sitz in</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zug</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">I.	Corporate Name, Registered Office, Duration and Purpose of the Company</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">I.	Firma, Sitz, Dauer und Zweck der Gesellschaft</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 1	Corporate Name, Registered Office and Duration</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Under the name</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oculis Holding AG <br>(Oculis Holding SA)<br>(Oculis Holding Ltd)</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a company limited by shares which is subject to the provisions of articles 620 et seq. of the Swiss Code of Obligations (CO) exists with registered office in Zug (Switzerland) (the &#34;Company&#34;). The duration of the Company is unlimited.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 1	Firma, Sitz und Dauer<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Unter der Firma</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oculis Holding AG <br>(Oculis Holding SA)<br>(Oculis Holding Ltd)</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">besteht eine Aktiengesellschaft gem&auml;ss Artikeln 620 ff. OR mit Sitz in Zug (Schweiz) (die &#34;Gesellschaft&#34;). Die Dauer der Gesellschaft ist unbeschr&auml;nkt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 2	Purpose</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The purpose of the Company is to acquire, hold, manage and sell interests in companies of all kinds in Switzerland and abroad, in particular in the areas of research and development in the field of pharmaceutical products, including biological and biotechnological products, as well as the production and commercialisation of such products.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 2	Zweck</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft bezweckt den Erwerb, das Halten, die Verwaltung und die Ver&auml;usserung von Beteiligungen an Gesellschaften aller Art in der Schweiz und im Ausland, insbesondere in den Bereichen Forschung und Entwicklung auf dem Gebiet von pharmazeutischen Produkten, einschliesslich bio-logischen und biotechnologischen Produkten, sowie die Herstellung und Kommerzialisierung derartiger Produkte.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">2</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company may purchase, hold and sell patents, copyrights, trademarks and other intellectual property rights as well as licenses of any kind.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann Patente, Urheber-rechte, Marken und andere Immaterialg&uuml;terrechte sowie Lizenzen jeder Art erwerben, halten und ver&auml;ussern.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company may engage in and carry out any and all commercial, financial or other activity, which is directly or indirectly related to the purpose of the Company. The Company may purchase, hold and sell shares or interests in other companies in Switzerland or abroad. It may establish and maintain branches and subsidiaries in Switzerland and abroad.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann alle kommerziellen, finanziellen und anderen T&auml;tigkeiten aus&uuml;ben, welche mit dem Zweck der Gesellschaft direkt oder indirekt im Zusammenhang stehen. Die Gesellschaft kann Beteiligungen an anderen Unternehmen im In- und Ausland erwerben, halten und ver&auml;ussern. Sie kann Zweigniederlassungen und Tochtergesellschaften im In- und Ausland errichten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company may purchase, hold and sell real estate and carry out other investments.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann Grundst&uuml;cke erwerben, verwalten und ver&auml;ussern sowie Verm&ouml;gensanlagen anderer Art t&auml;tige.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">II.	SHARE CAPITAL, SHARES AND SHARE REGISTER</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">II.	AKTIENKAPITAL, AKTIEN UND AKTIENBUCH</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3	Share Capital and Shares</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The share capital of the Company is CHF 464'437.00 and is fully paid-in. It is divided into 46'443'700 registered shares with a nominal value of CHF 0.01 each.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3	Aktienkapital und Aktien</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Aktienkapital der Gesellschaft betr&auml;gt CHF 464'437.00 und ist voll liberiert. Es ist in 46'443'700 Namenaktien mit einem Nennwert von je CHF 0.01 eingeteilt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3a	Capital Band</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company has a capital band between CHF 464'437.00 (lower limit) and CHF 691'655.50 (upper limit).</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors is authorized to increase the share capital up to the upper limit at any time and as often as required until 29 May 2029.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The increase must be effected by issuing a maximum of 22'721'850 registered shares with a par value of CHF 0.01, to be fully paid up. After a change in par value, the new par value shall also apply within the scope of the capital band. A capital reduction is excluded.	<br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3a	Kapitalband</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft hat ein Kapitalband zwischen CHF 464'437.00 (untere Grenze) und CHF 691'655.50 (obere Grenze).</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat ist erm&auml;chtigt, bis zum 29. Mai 2029 das Aktienkapital jederzeit und beliebig oft bis zur oberen Grenze zu erh&ouml;hen.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Erh&ouml;hung hat durch Ausgabe von maximal 22'721'850 vollst&auml;ndig zu liberierenden Namenaktien im Nennwert von CHF 0.01 zu erfolgen. Nach einer Nennwertver&auml;nderung gilt der neue Nennwert auch im Rahmen des Kapitalbandes. Eine Kapitalherabsetzung wird ausgeschlossen.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erh&ouml;ht sich das Aktienkapital aufgrund einer Erh&ouml;hung aus bedingtem Kapital gem&auml;ss Art 3b, 3c, 3d oder 3e der Statuten, so erh&ouml;hen sich die obere und die</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">3</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If the share capital increases as a result of an increase from conditional capital pursuant to Article 3b, 3c, 43d or 3e of these articles of association, the upper and lower limits of the capital range shall increase in an amount corresponding to such increase in the share capital.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">untere Grenze des Kapitalbands entsprechend dem Umfang der Erh&ouml;hung des Aktienkapitals.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">An increase of the share capital (i) by subscription of shares based on an offer signed by a financial institution, an association, another third party or third parties, followed by an offer to the then existing shareholders of the Company, (ii) by subscription of shares at par value out of the Company's equity with a view towards the (private) placement or sale of these shares as part of a fast and flexible fundraising process as well as (iii) in partial amounts is permitted.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Eine Erh&ouml;hung des Aktienkapitals (i) durch die Zeichnung von Aktien aufgrund eines von einem Finanzinstitut, eines Verbandes, einer anderen Drittpartei oder Drittparteien unterzeichneten Angebots, gefolgt von einem Angebot gegen&uuml;ber den zu diesem Zeitpunkt bestehenden Aktion&auml;ren der Gesellschaft, (ii) durch Zeichnung von Aktien zum Nennwert aus dem Eigenkapital der Gesellschaft mit Hinblick auf die (private) Platzierung oder der Verkauf dieser Aktien im Rahmen eines schnellen und flexiblen Fundraising-Prozesses sowie (iii) in Teilbetr&auml;gen ist zul&auml;ssig.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall determine the time of the issuance, the issue price, the manner in which the new registered shares have to be paid up, the date from which the registered shares carry the right to dividends, the conditions for the exercise of the preemptive rights and the allotment of preemptive rights that have not been exercised. The Board of Directors may allow the preemptive rights that have not been exercised to expire, or it may place with third parties such rights or registered shares, the preemptive rights of which have not been exercised, at market conditions or use them otherwise in the interest of the Company.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat soll den Ausgabezeitpunkt, den Bezugspreis, die Art und Weise der Liberierung, das Datum, ab welchem die Aktien zum Bezug einer Dividende berechtigen, die Bedingungen zur Aus&uuml;bung der Bezugsrechte sowie die Zuteilung nicht ausge&uuml;bter Bezugsrechte festlegen. Der Verwaltungsrat kann bestimmen, dass nicht ausge&uuml;bte Bezugsrechte verfallen oder er kann Drittparteien solche Rechte oder Aktien, f&uuml;r welche die Bezugsrechte nicht ausge&uuml;bt wurden, zu Marktbedingungen zuteilen oder sie sonst im Interesse der Gesellschaft verwenden.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors is authorized to withdraw or limit the preemptive rights of the shareholders and to allot them to third parties:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">if the issue price of the new registered shares is determined by reference to the market price; or</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">for the acquisition of an enterprise, part of an enterprise or </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat ist erm&auml;chtigt, das Bezugsrecht der Aktion&auml;re auszuschliessen oder Dritten zuzuteilen: 	 <br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">falls der Ausgabepreis der neuen Aktien anhand des Marktwertes festgelegt wird; oder</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">f&uuml;r die &Uuml;bernahme eines Unternehmens, den Teil eines Unternehmens oder Beteiligungen oder f&uuml;r die Finanzierung oder Refinanzierung solcher </font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">4</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">participations, or for the financing or refinancing of any of such acquisition, or in the event of share placement for the financing or refinancing of such placement; or	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">for purposes of broadening the shareholder constituency of the Company in certain financial or investor markets, for purposes of the participation of strategic partners, or in connection with the listing or registration of new registered shares on domestic or foreign stock exchanges; or	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">for purposes of granting an over-allotment option (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;font-style:italic;min-width:fit-content;">Greenshoe</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">) or an option to subscribe additional shares to the respective initial purchaser(s) or underwriter(s) in a placement or sale of registered shares; or	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	for raising of capital (including private placements) in a fast and flexible way, which probably could not be reached without the exclusion of the statutory pre-emptive right of the existing shareholders; <br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">for other valid grounds in the sense of article 652b para. 2 CO; or</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered in the commercial register without having submitted to the other shareholders a takeover offer recommended by the Board of Directors, or for the defense of an actual, threatened or potential takeover bid, in relation to which the Board of Directors, upon consultation with an independent financial adviser </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erwerbe, oder im Falle einer Aktienplatzierung f&uuml;r die Finanzierung oder Refinanzierung solcher Platzierungen; oder</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">zum Zweck der Erweiterung der Aktion&auml;rskreises der Gesellschaft in bestimmten finanziellen oder Investorenm&auml;rkten, f&uuml;r die Zwecke der Beteiligung von strategischen Partnern, oder im Zusammenhang mit der Auflistung oder Meldung neuer Namenaktien an inl&auml;ndischen oder ausl&auml;ndischen B&ouml;rsen; oder</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">zum Zweck der Gew&auml;hrung einer Mehrzuteilungsoption (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;font-style:italic;min-width:fit-content;">Greenshoe</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">) oder eine Option zur Zeichnung von zus&auml;tzlichen Aktien an die betreffenden Erstk&auml;ufer oder Fest&uuml;bernehmer im Rahmen einer Aktienplatzierung oder eines Aktienverkaufs; oder</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">um Kapital (inklusive durch private Vermittlung) in schneller und flexibler Weise zu beschaffen, welches wahrscheinlich ohne den Ausschluss der gesetzlichen Vorkaufsrechte der existierenden Aktion&auml;re nicht erhoben werden k&ouml;nnte; oder </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">aus anderen, gem&auml;ss Artikel 652 Abs. 2 OR zul&auml;ssigen Gr&uuml;nden; oder </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">einem Aktion&auml;r oder einer Gruppe von Aktion&auml;ren folgend, die gemeinsam mehr als 15% des im Handelsregister eingetragenen Aktienkapitals halten und den &uuml;brigen Aktion&auml;ren auf Empfehlung des Verwaltungsrats hin kein &Uuml;bernahmeangebot unterbreitet haben, oder im Rahmen der Abwehr eines tats&auml;chlichen, drohenden oder etwaigen &Uuml;bernahmeversuchs, f&uuml;r den der Verwaltungsrat, nach Konsultation eines unabh&auml;ngigen Finanzberaters, keine Zustimmungsempfehlung abgegeben hat, da das &Uuml;bernahmeangebot vom Verwaltungsrat den Aktion&auml;ren gegen&uuml;ber als finanziell zu wenig angemessen betrachtet wird.</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">5</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">retained by it, has not recommended to the shareholders acceptance on the basis that the Board of Directors has not found the takeover bid to be financially fair to the shareholders.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The acquisition of registered shares and any transfers of registered shares shall be subject to the restrictions specified in article 4 of the articles of association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Erwerb von Namenaktien sowie jeder Transfer von Namenaktien unterliegen den Einschr&auml;nkungen in Artikel 4 dieser Statuten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3b	Conditional Share Capital for Bonds and Similar Debt Instruments	<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The share capital of the Company may be increased by the maximum amount of CHF 67'500.00 by issuing up to 6'750'000 fully paid-up registered shares with a nominal value of CHF 0.01 each, through the exercise of conversion and/or option rights or warrants or granted in connection with bonds or similar instruments, assumed, issued or to be issued by the Company or by its subsidiaries, including convertible debt instruments. The exercise of the conversion and/or option rights and the waiver of such right shall be made in writing on paper or in electronic form.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3b	Bedingtes Aktienkapital f&uuml;r Anleihensobligationen oder &auml;hnliche Instrumente</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Aktienkapital der Gesellschaft wird im Maximalbetrag von CHF 67'500.00 erh&ouml;ht durch Ausgabe von h&ouml;chstens 6'750'000 vollst&auml;ndig zu liberierenden Namenaktien mit einem Nennwert von je CHF 0.01 durch Aus&uuml;bung von Wandlungs- und/oder Optionsrechten, welche im Zusammenhang mit van der Gesellschaft oder ihren Tochtergesellschaften &uuml;bernommenen oder emittierten Anleihensobligationen oder &auml;hnlichen Instrumenten einger&auml;umt wurden oder werden, einschliesslich Wandelanleihen. Die Form der Aus&uuml;bung der Wandlungs- und/oder Optionsrechte und des Verzichts auf dieses Recht erfolgt auf schriftlichem Weg auf Papier oder in elektronischer Form.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholders' subscription rights for these shares are excluded. Shareholders' advance subscription rights with regard to the new bonds or similar instruments may be restricted or excluded by decision of the Board of Directors in order to finance or re-finance the acquisition of companies, parts of companies or holdings, or new investments planned by the Company, or in order to issue convertible bonds or similar instruments on the international capital markets or through private placement. If advance subscription rights are excluded, then (1) the instruments are to be placed at market conditions, (2) the exercise period</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Bezugsrecht der Aktion&auml;re ist f&uuml;r diese Aktien ausgeschlossen. Das Vorwegzeichnungsrecht der Aktion&auml;re in Bezug auf neue Anleihensobligationen oder &auml;hnliche Instrumente kann durch Beschluss des Verwaltungsrates zu folgenden Zwecken eingeschr&auml;nkt oder ausgeschlossen werden: Finanzierung und Refinanzierung des Erwerbs von Unternehmen, Unternehmensteilen, Beteiligungen, oder von der Gesellschaft geplanten neuen Investitionen, oder f&uuml;r die Ausgabe von Anleihensobligationen oder &auml;hnlichen Instrumenten auf internationalen Kapitalm&auml;rkten oder mittels Privatplatzierungen. Falls Vorwegzeichnungsrechte ausgeschlossen werden, m&uuml;ssen (1) die Instrumente zu Marktkonditionen platziert werden, (2) der Aus&uuml;bungszeitraum darf zehn Jahre seit dem</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">6</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">is not to exceed ten years from the date of issue of option rights and twenty years for conversion rights and (3) the conversion or exercise price for the new shares is to be set at least in line with the market conditions prevailing at the date on which the instruments are issued. In addition, advance subscription rights can also be excluded if the instruments to be issued are granted or issued within the context of a larger transaction concluded at market conditions, in which case the conversion or exercise price for the new shares can be set by accounting for the general economic terms of the transaction, which may provide for the payment of the conversion or exercise price at nominal value, through a cashless settlement mechanism and/or through adjusted rights under the instruments themselves.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ausgabedatum der Optionsrechte und 20 Jahre seit dem Ausgabedatum der Wandlungsrechte nicht &uuml;berschreiten und (3) der Wandlungs- oder Aus&uuml;bungspreis f&uuml;r die neuen Aktien muss mindestens gem&auml;ss den Marktbedingungen am Ausgabedatum der Instrumente festgelegt werden. Dar&uuml;ber hinaus kann das Vorwegzeichnungsrecht auch ausgeschlossen werden, wenn die auszugebenden Instrumente im Rahmen einer umfangreicheren, zu Marktbedingungen abgeschlossenen Transaktion gew&auml;hrt oder ausgegeben werden; in diesem Fall kann der Wandlungs- oder Aus&uuml;bungspreis f&uuml;r die neuen Aktien unter Ber&uuml;cksichtigung der allgemeinen wirtschaftlichen Bedingungen der Transaktion festgelegt werden, die die Zahlung des Wandlungs- oder Aus&uuml;bungspreises zum Nennwert, durch einen bargeldlosen Abwicklungsmechanismus und/oder durch angepasste Rechte aus den Instrumenten selbst vorsehen k&ouml;nnen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The acquisition of registered shares through the exercise of conversion rights or warrants and any transfers of registered shares shall be subject to the restrictions specified in article 4 of the articles of Association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Erwerb von Namenaktien durch Aus&uuml;bung von Wandelrechten oder Warrants sowie s&auml;mtliche weiteren &Uuml;bertragungen von Namenaktien unterliegen den &Uuml;bertragungsbeschr&auml;nkungen gem&auml;ss Artikel 4 der Statuten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3c	Conditional Share Capital for Employee Benefit Plans</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The share capital of the Company shall be increased by an amount not exceeding CHF 95'663.02 through the issue of a maximum of 9'566'302 registered shares, payable in full, each with a nominal value of CHF 0.01, in connection with the exercise of option rights or other equity-linked instruments granted to any employee of the Company or a subsidiary, and any consultant, members of the Board of Directors, or other person providing services to the Company or a subsidiary. The exercise of the option rights and the waiver of such right shall be</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3c	Bedingtes Aktienkapital f&uuml;r Mitarbeiterbeteiligungspl&auml;ne</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Aktienkapital kann durch die Ausgabe von h&ouml;chstens 9'566'302 voll zu liberierenden Namenaktien im Nennwert von je CHF 0.01 um h&ouml;chstens CHF 95'663.02 durch Aus&uuml;bung von Optionsrechten oder anderen eigenkapitalbasierten Instrumenten erh&ouml;ht werden, welche Mitarbeitenden der Gesellschaft oder ihrer Tochtergesellschaften, Personen in vergleichbaren Positionen, Beratern, Verwaltungsratsmitgliedern oder anderen Personen, welche Dienstleistungen zu Gunsten der Gesellschaft erbringen, gew&auml;hrt wurden. Die Form der Aus&uuml;bung der Optionsrechte und des Verzichts auf dieses Recht erfolgt auf schriftlichem Weg auf Papier oder in elektronischer Form.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">7</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">made in writing on paper or in electronic form.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholders' subscription rights shall be excluded with regard to these shares. These new registered shares may be issued at a price below the current market price. The Board of Directors shall specify the precise conditions of issue including the issue price of the shares.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Bezugsrecht der Aktion&auml;re ist f&uuml;r diese Aktien ausgeschlossen. Diese neuen Namenaktien k&ouml;nnen zu einem Preis unter dem aktuellen Marktpreis ausgegeben werden. Der Verwaltungsrat legt die genauen Bedingungen f&uuml;r die Ausgabe, einschliesslich des Ausgabepreises der Aktien fest.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The acquisition of registered shares in connection with employee participation and any further transfers of registered shares shall be subject to the restrictions specified in article 4 of the articles of association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Erwerb von Namenaktien im Zusammenhang der Mitarbeiterbeteiligung sowie s&auml;mtliche weiteren &Uuml;bertragungen von Namenaktien unterliegen den &Uuml;bertragungsbeschr&auml;nkungen gem&auml;ss Artikel 4 der Statuten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3d	Conditional Share Capital for EBAC-Warrants</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The share capital shall be increased by an amount not exceeding CHF 42'541.38 through the issue of a maximum of 4'254'138 registered shares, payable in full, each with a nominal value of CHF 0.01. The increase of the share capital shall occur in connection with the share capital increase of 1 March 2023 through the exercise of conversion and/or option rights, which were assumed from, and allocated by, European Biotech Acquisition Corp. with registered seat in George Town, Cayman Islands and business address at EPFL Innovation Park Building D, 1015 Lausanne, Switzerland (EBAC), at an exercise price of USD 11.50 on the basis of a Warrant Assumption Agreement between the Company and Continental Stock Transfer &amp; Trust Company, with registered seat in New York (USA) as Warrant Agent. The exercise of conversion and/or option rights and the waiver of such right shall be made in writing on paper or in electronic form.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3d	Bedingtes Aktienkapital f&uuml;r EBAC-Warrants</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Aktienkapital kann durch die Ausgabe von h&ouml;chstens 4'254'138 voll zu liberierenden Namenaktien im Nennwert von je CHF 0.01 um h&ouml;chstens CHF 42'541.38 erh&ouml;ht werden. Die Erh&ouml;hung des Aktienkapitals erfolgt im Zusammenhang mit der Kapitalerh&ouml;hung vom 1. M&auml;rz 2023 durch die Aus&uuml;bung von Wandlungs- und/oder Optionsrechten, welche von European Biotech Acquisition Corp. mit Sitz in George Town, Cayman Islands und Gesch&auml;ftsadresse an der EPFL Innovation Park Building D, 1015 Lausanne, Schweiz (EBAC), mit einem Aus&uuml;bungspreis von USD 11.50 auf der Grundlage eines Warrant Assumption Agreements zwischen der Gesellschaft und Continental Stock Transfer &amp; Trust Company, mit Sitz in New York (USA) als Warrant Agent, &uuml;bernommenen und einger&auml;umt wurden. Die Form der Aus&uuml;bung der Wandlungs- und/oder Optionsrechte und des Verzichts auf dieses Recht erfolgt auf schriftlichem Weg auf Papier oder in elektronischer Form.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Only the bearers of such conversion and/or option rights shall be entitled to</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zum Bezug der neuen Namenaktien sind die Inhaber von Wandlungs- und/oder Optionsrechten berechtigt.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">8</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">obtain such new registered shares. The terms and conditions of the exercise and/or conversion rights, such as the exercise and/or conversion price and period, the time of entitlement to dividends and the type of contributions shall be defined by the Board of Directors</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Bezugsbedingungen, wie Aus&uuml;bungs- und/oder Konvertierungspreis und -frist, Zeitpunkt der Dividendenberechtigung und Art der Einlagen, werden durch den Verwaltungsrat festgelegt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The shareholders' subscription rights are excluded for these shares. The shareholders&#x2019; advance subscription rights regarding these Warrants are excluded to abide by the obligations stemming from the Business Combination Agreement dated 17 October 2022 between EBAC and Oculis SA with registered seat in Ecublens (VD), Switzerland, and assumed by the Company.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Bezugsrecht der Aktion&auml;re ist f&uuml;r diese Aktien ausgeschlossen. Das Vorwegzeichnungsrecht der Aktion&auml;re in Bezug auf diese Warrants ist ausgeschlossen, um die im Business Combination Agreement vom 17. Oktober 2022 zwischen EBAC und Oculis SA mit Sitz in Ecublens (VD), Schweiz, eingegangenen und von der Gesellschaft &uuml;bernommenen Verpflichtungen zu erf&uuml;llen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The acquisition of registered shares through the exercise of conversion and/or option rights and the further transfer of registered shares shall be subject to the restrictions specified in article 4 of the articles of association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Erwerb von Namenaktien durch die Aus&uuml;bung von Wandlungs- und/oder Optionsrechten sowie s&auml;mtliche weiteren &Uuml;bertragungen von Namenaktien unterliegen den &Uuml;bertragungsbeschr&auml;nkungen gem&auml;ss Artikel 4 der Statuten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 3e	Conditional Share Capital for Earn-Out Options</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The share capital of the Company shall be increased by an amount not exceeding CHF 3'701.03 through the issue of a maximum of 370'103 registered shares, payable in full, each with a nominal value of CHF 0.01, in connection with the exercise of option rights granted in connection with the Business Combination Agreement dated 17. October 2022 between European Biotech Acquisition Corp. with registered seat in George Town, Cayman Islands and business address at EPFL Innovation Park Building D, 1015 Lausanne, Switzerland (EBAC) and Oculis SA with registered seat in Ecublens (VD), Switzerland, to any employee of the Company or a subsidiary, and any consultant, members of the Board of Directors, or other person</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 3e	Bedingtes Aktienkapital f&uuml;r Earn-Out Optionen</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Aktienkapital kann durch die Ausgabe von h&ouml;chstens 370'103 voll zu liberierenden Namenaktien im Nennwert von je CHF 0.01 um h&ouml;chstens CHF 3'701.03 durch Aus&uuml;bung von Optionsrechten erh&ouml;ht werden, welche Mitarbeitenden der Gesellschaft oder ihrer Tochtergesellschaften, Personen in vergleichbaren Positionen, Beratern, Verwaltungsratsmitgliedern oder anderen Personen, welche Dienstleistungen zu Gunsten der Gesellschaft erbringen, und im Zusammenhang mit dem Business Combination Agreement vom 17. Oktober 2022 zwischen European Biotech Acquisition Corp. mit Sitz in George Town, Cayman Islands und Gesch&auml;ftsadresse an der EPFL Innovation Park Building D, 1015 Lausanne, Schweiz (EBAC) und Oculis SA mit Sitz in Ecublens (VD), Schweiz zus&auml;tzlich einger&auml;umt wurden (</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;font-style:italic;min-width:fit-content;">earn-out</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;Optionen). Die Form der Aus&uuml;bung der Optionsrechte und des Verzichts</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">9</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">providing services to the Company or a subsidiary (earn-out options). The exercise of the option rights and the waiver of such right shall be made in writing on paper or in electronic form.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">auf dieses Recht erfolgt auf schriftlichem Weg auf Papier oder in elektronischer Form.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholders' subscription rights shall be excluded with regard to these shares. These new registered shares may be issued at a price below the current market price. The Board of Directors shall specify the precise conditions of issue including the issue price of the shares.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Bezugsrecht der Aktion&auml;re ist f&uuml;r diese Aktien ausgeschlossen. Diese neuen Namenaktien k&ouml;nnen zu einem Preis unter dem aktuellen Marktpreis ausgegeben werden. Der Verwaltungsrat legt die genauen Bedingungen f&uuml;r die Ausgabe, einschliesslich des Ausgabepreises der Aktien.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The acquisition of registered shares in connection with employee participation and any further transfers of registered shares shall be subject to the restrictions specified in article 4 of the articles of association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Erwerb von Namenaktien im Zusammenhang der Mitarbeiterbeteiligung sowie s&auml;mtliche weiteren &Uuml;bertragungen von Namenaktien unterliegen den &Uuml;bertragungsbeschr&auml;nkungen gem&auml;ss Artikel 4 der Statuten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 4	Share Register</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company shall maintain a share register in which it shall register the name, first name and place of residence (in case of legal persons the place of incorporation) of the owners and usufructuaries of its registered shares. Natural and legal persons as well as legal representatives of minors etc. entitled by law to the voting rights of a share which they do not own will be noted in the share register upon request.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 4	Aktienbuch</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft f&uuml;hrt ein Aktienbuch, worin die Eigent&uuml;mer und Nutzniesser von Namenaktien mit Namen, Vornamen und Wohnort (bei juristischen Personen Sitz) eingetragen werden. Nat&uuml;rliche und juristische Personen sowie gesetzliche Vertreter von Minderj&auml;hrigen usw., welchen kraft Gesetzes Stimmrechte eines Anteils zukommen, den sie nicht besitzen, werden auf Anfrage im Aktienregister angemerkt.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">10</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Upon request, acquirers of shares will be registered in the share register without limitation as shareholders if they expressly certify that they acquired the shares in their own name and for their own account.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erwerber von Aktien werden auf Gesuch hin ohne Begrenzung als Aktion&auml;re mit Stimmrecht im Aktienregister eingetragen, falls sie ausdr&uuml;cklich erkl&auml;ren, die Aktien im eigenen Namen und auf eigene Rechnung erworben zu haben.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Persons who do not expressly declare in the registration application that they are holding the shares on their own account (thereafter: nominees) shall forthwith be entered on the share register as shareholders with voting rights up to a maximum of 3% of the share capital. Beyond that limit, registered shares of nominees shall only be entered as voting if the nominees in question confirm in writing that they are willing to disclose the names, addresses and shareholdings of the persons on whose account they hold 0.5% or more of the share capital. The Board of Directors concludes agreements with nominees that among other things govern the representation of shareholders and the voting rights.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Personen, die im Eintragungsgesuch nicht ausdr&uuml;cklich erkl&auml;ren, die Aktien f&uuml;r eigene Rechnung zu halten (nachstehend: Nominees) werden ohne weiteres bis maximal 3% des jeweils ausstehenden Aktienkapitals mit Stimmrecht im Aktienbuch eingetragen. &Uuml;ber diese Limite hinaus werden Namenaktien von Nominees nur dann mit Stimmrecht eingetragen, wenn sich der betreffende Nominee schriftlich bereit erkl&auml;rt, gegebenenfalls die Namen, Adressen und Aktienbest&auml;nde derjenigen Person offenzulegen, f&uuml;r deren Rechnung er 0.5% oder mehr des jeweils ausstehenden Aktienkapitals h&auml;lt. Der Verwaltungsrat schliesst mit Nominees Vereinbarungen ab, die unter anderem die Vertretung der Aktion&auml;re und der Stimmrechte regeln.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">After hearing the registered shareholder or nominee, the Board of Directors may remove entries in the share register with retroactive effect as per the date of entry, if such entry was based on false information. The party affected must be informed of such removal immediately.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Nach Anh&ouml;rung des eingetragenen Aktion&auml;rs oder Nominees, kann der Verwaltungsrat die Eintragungen im Aktienregister r&uuml;ckwirkend nach dem Datum der Eintragung entfernen, wenn ein solcher Eintrag aufgrund falscher Angaben erfolgte. Der Betroffene muss &uuml;ber eine solche Entfernung sofort informiert werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">No individual or legal entity may, directly or indirectly, formally, constructively or beneficially own (as defined in the next paragraph below) or otherwise control voting rights (&#34;Controlled Shares&#34;) with respect to 15% or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity has submitted prior to the acquisition of such Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Weder eine Einzelperson, noch eine juristische Person kann, direkt oder indirekt, formell, konstruktiv oder vorteilhaft (wie im n&auml;chsten Abschnitt unten definiert) oder sonst wie das Stimmrecht (&#34;Kontrollierte Aktien&#34;) hinsichtlich 15% oder mehr des im Handelsregister registrierten Aktienkapitals innehaben oder kontrollieren. Eine Ausnahme besteht dann, wenn diese Einzelperson oder juristische Person vor der &Uuml;bernahme solcher Kontrollierter Aktien allen Aktion&auml;ren eine ordentliche Offerte mit einem Minimalpreis stellt, wovon der h&ouml;here Preis, der entweder (i) dem gewichteten Durchschnittskurs der letzten 60 Handelstage vor der Ver&ouml;ffentlichung der</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">11</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">last 60 trading days prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, shall be regarded as one person. The registered shares exceeding the limit of 15% and not benefiting from the exemption regarding a tender offer shall be entered in the share register as shares without voting rights.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&Uuml;bernahmeofferte oder (ii) dem h&ouml;chsten bezahlten Preis durch diese Einzelperson oder juristische Person w&auml;hrend der 12 Monate vor der Ver&ouml;ffentlichung der &Uuml;bernahmeofferte entspricht, der relevante Preis darstellt. Die durch Kapital, Stimmrecht, gemeinsame F&uuml;hrung oder in anderer Weise oder durch Beitritt zur &Uuml;bernahme der Aktien verbundenen Personen, sind als eine Person zu betrachten. Die Namenaktien, welche die Limite von 15% &uuml;bersteigen und nicht von der Ausnahme mit Bezug auf die &Uuml;bernahmeofferte profitieren, sollen im Aktienbuch als Aktien ohne Stimmrecht verzeichnet werden.</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">For the purposes of this article 4, &#34;Controlled Shares&#34; in reference to any individual or entity means:	<br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a)	all shares of the Company directly, indirectly or constructively owned by such individual or entity; provided that 	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(i) 	shares owned, directly or indirectly, by or for a partnership, or trust or estate will be considered as being owned proportionately by its partners, or beneficiaries; and</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> <br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(ii)	shares owned, directly or indirectly, by or for a corporation will be considered as being owned proportionately by any shareholder owning 50% or more of the outstanding voting shares of such corporation; and</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(iii)	shares subject to options, warrants or other similar rights shall be deemed to be owned; and</font></p><p style="text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(b)</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">all shares of the Company directly, indirectly or beneficially owned by</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Im Rahmen dieses Artikel 4 bedeuten &#34;Kontrollierte Aktien&#34; in Bezug auf jegliche Einzelperson oder juristische Person:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a)	alle Aktien der Gesellschaft, die direkt, indirekt oder konstruktiv von einer solchen Einzelperson oder juristischen Person gehalten werden; vorausgesetzt dass</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(i) 	Aktien, die direkt oder indirekt durch oder f&uuml;r eine Personengesellschaft oder einen Trust oder eine Verm&ouml;gensmasse gehalten werden, proportional auf die Partner oder Beg&uuml;nstigten aufgeteilt werden; und</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(ii)	Aktien, die direkt oder indirekt durch oder f&uuml;r eine Gesellschaft gehalten werden, proportional auf jeden Aktion&auml;r, der 50% oder mehr der ausgegebenen Stimmrechtsaktien besitzt, aufgeteilt werden; und</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(iii)	Aktien, die in Abh&auml;ngigkeit zu Optionen, Bezugsrechten oder anderen &auml;hnlichen Rechten stehen, als Eigentum gelten; und</font></p><p style="text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(b)</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">alle Aktien der Gesellschaft, die direkt, indirekt oder vorteilhaft durch eine solche Einzelperson oder eine juristische Person gehalten werden, vorausgesetzt dass</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(i)	ein beg&uuml;nstigter Eigent&uuml;mer eines Wertpapiers jede Person umfasst, die direkt oder indirekt, durch jede Art von Vertrag, Vereinbarung, Einvernehmen, Bindung oder</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">12</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.25pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-left:21.25pt;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">such individual or entity; provided that</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(i)	a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise alone or together with other such persons has or shares:	<br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:42.55pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(1)	voting power which includes the power to vote, or to direct the voting of, such security; and/or</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	<br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:42.55pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(2)	investment power which includes the power to dispose, or to direct the disposition of, such security.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> 	<br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(ii)	Any person who, directly or indirectly, creates or uses a trust, proxy, power of attorney, pooling arrangement or any other contract, arrangement, or device with the purpose or effect of divesting such person of beneficial ownership of shares of the Company or preventing the vesting of such beneficial ownership as part of a plan or scheme to evade the provisions of these articles of association shall be deemed to be the beneficial owner of such shares.	</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> <br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(iii)	A person shall be deemed to be the beneficial owner of shares if that person has the right to acquire beneficial ownership of</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:42.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="margin-left:42.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">anderweitig allein oder mit anderen Personen gemeinsam hat oder teilt:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:42.55pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(1)	das Stimmrecht, welches das Recht zur Stimmabgabe, oder zur Leitung der Stimme eines solchen Wertpapiers umfasst; und/oder</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:42.55pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(2)	das Investitionsrecht, welches die Verf&uuml;gungsmacht oder ein Recht zur Bestimmung &uuml;ber die Verf&uuml;gung eines solchen Wertpapiers umfasst.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(ii)	Jede Person, die, direkt oder indirekt, einen Trust, Stellvertretung, Vollmacht, Pooling-Vertrag oder jede andere Form von Vertrag, mit dem Zweck oder Ziel schafft oder benutzt, um eine Person von ihren wirtschaftlichen Beg&uuml;nstigungen aus dem Eigentum an den Aktien der Gesellschaft zu entheben oder zur Verhinderung der Aus&uuml;bung eines solchen beg&uuml;nstigenden Eigentums als Teil eines Plans oder Vorhabens zur Umgehung der Regelungen in diesen Statuten, soll als beg&uuml;nstigter Eigent&uuml;mer solcher Aktien gesehen werden.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="margin-left:21.25pt;text-indent:-21.25pt;padding-left:21.25pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(iii)	Eine Person soll als beg&uuml;nstigter Eigent&uuml;mer von Aktien eingestuft werden, wenn diese Person das Recht hat, ein beg&uuml;nstigendes Eigentum an solchen Aktien innerhalb von 60 Tagen zu erwerben, inklusive, aber nicht beschr&auml;nkt auf jegliches erworbenes Recht: (A) durch die Aus&uuml;bung jeglicher Option, jedes Bezugsrechts oder sonstigen Rechts; (B) durch die Umwandlung eines Wertpapiers; (C) aufgrund der Befugnis, einen Trust, ein Verm&ouml;gensverwaltungskonto oder &auml;hnliche Verh&auml;ltnisse zu widerrufen oder (D) in Zusammenhang mit der automatischen Aufl&ouml;sung eines Trusts, Verm&ouml;gensverwaltungskontos oder eines &auml;hnlichen Verh&auml;ltnisses.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">13</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:42.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-left:42.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">such shares within 60 days, including but not limited to any right acquired: (A) through the exercise of any option, warrant or right; (B) through the conversion of a security; (C) pursuant to the power to revoke a trust, discretionary account, or similar arrangement; or (D) pursuant to the automatic termination of a trust, discretionary account or similar arrangement.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The limit of 15% of the registered share capital also applies to the subscription for, or acquisition of, registered shares by exercising option or convertible rights arising from registered or bearer securities or any other securities issued by the Company or third parties, as well as by means of exercising purchased preemptive rights arising from either registered or bearer shares. The registered shares exceeding the limit of 15% shall be entered in the share register as shares without voting rights.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Grenze von 15% des eingetragenen Aktienkapitals gilt auch f&uuml;r zur Zeichnung von, oder Akquisition von Namenaktien durch Aus&uuml;bung einer Option oder umwandelbaren Rechte, welche aus Namen- oder Inhaberaktien hervor gehen oder jeder anderen von der Gesellschaft oder Dritten ausgegebenen Sicherheit, sowie durch die Aus&uuml;bung von erworbenen Vorkaufsrechten, welche entweder aus Namen- oder Inhaberaktien hervorgehen. Die Namenaktien, welche die Grenze von 15% &uuml;bersteigen, sind im Aktienbuch als Aktien ohne Stimmrecht einzutragen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors may in special cases approve exceptions to the above regulations. The Board of Directors is in addition authorized, after due consultation with the person concerned, to delete with retroactive effect entries in the share register which were effected on the basis of false information.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat kann in besonderen F&auml;llen Ausnahmen zu den oben genannten Regelungen genehmigen. Der Verwaltungsrat ist zus&auml;tzlich berechtigt, nach angemessener Anh&ouml;rung der betreffenden Person, Eintr&auml;ge ins Aktienbuch, welche aufgrund falscher Informationen erfolgten, r&uuml;ckwirkend zu l&ouml;schen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 5	Reporting Obligation of the Shareholder and Register of Beneficial Owners</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 5	Meldepflicht des Aktion&auml;rs und Verzeichnis der wirtschaftlich berechtigten Personen</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Any person who, alone or in concert with third parties, acquires shares in the Company and thereby reaches or exceeds the threshold of 25% of the share capital or voting rights must notify the Company within one month of the first name, last</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Wer allein oder in gemeinsamer Absprache mit Dritten Aktien der Gesellschaft erwirbt und dadurch den Grenzwert von 25% des Aktienkapitals oder der Stimmrechte erreicht oder &uuml;berschreitet, muss der Gesellschaft innert Monatsfrist den Vor- und den Nach-namen und die Adresse der nat&uuml;rlichen Person</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">14</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">name and address of the natural person on whose behalf he is ultimately acting (beneficial owner).</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">melden, f&uuml;r die er letztendlich handelt (wirtschaftlich berechtigte Person).</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The shareholder must notify the company within three months of any change in the first or last name or address of the beneficial owner.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Aktion&auml;r muss der Gesellschaft innert drei Monaten jede &Auml;nderung des Vor- oder des Nachnamens oder der Adresse der wirtschaftlich berechtigten Person melden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall keep a register of the beneficial owners reported to the Company. This register contains the first and last name as well as the address of the beneficial owners. The register must be kept in such a way that it can be accessed in Switzerland at any time.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat f&uuml;hrt ein Verzeichnis &uuml;ber die der Gesellschaft gemeldeten wirtschaftlich berechtigten Personen. Dieses Verzeichnis enth&auml;lt den Vor- und den Nachnamen sowie die Adresse der wirtschaftlich berechtigten Personen. Das Verzeichnis muss so gef&uuml;hrt werden, dass in der Schweiz jederzeit darauf zugegriffen werden kann.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">As long as the shareholder has not fulfilled his reporting obligations, the membership rights associated with the shares whose acquisition must be reported shall be suspended. The property rights attached to such shares may only be exercised by the shareholder once he has complied with his notification obligations. If the shareholder fails to comply with his reporting obligations within one month after the acquisition of the shares, the property rights shall be forfeited. If the shareholder makes the notification at a later date, he may assert the property rights accruing as of that date. The Board of Directors shall ensure that no shareholders exercise their rights in breach of the reporting obligations.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Solange der Aktion&auml;r seinen Meldepflichten nicht nachgekommen ist, ruhen die Mitgliedschaftsrechte, die mit den Aktien verbunden sind, deren Erwerb gemeldet werden muss. Die Verm&ouml;gensrechte, die mit solchen Aktien verbunden sind, kann der Aktion&auml;r erst geltend machen, wenn er seinen Meldepflichten nachgekommen ist. Kommt der Aktion&auml;r seinen Meldepflichten nicht innert eines Monats nach dem Erwerb der Aktien nach, so sind die Verm&ouml;gensrechte verwirkt. Holt er die Meldung zu einem sp&auml;teren Zeitpunkt nach, so kann er die ab diesem Zeitpunkt entstehenden Verm&ouml;gensrechte geltend machen. Der Verwaltungsrat stellt sicher, dass keine Aktion&auml;re unter Verletzung der Melde-pflichten ihre Rechte aus&uuml;ben.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">15</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 6	Share Certificates and Intermediated Securities</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company may issue its shares in any legally permissible form, namely in the form of individual certificates, global certificates, simple uncertificated securities pursuant to article 973c CO or registered uncertificated securities pursuant to article 973d CO and have them managed as intermediated securities.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 6	Aktienzertifikate und Bucheffekten</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann ihre Aktien in jeder gesetzlich zul&auml;ssigen Form, namentlich in Form von Einzelurkunden, Globalurkunden, einfachen Wertrechten nach Artikel 973c OR oder Registerwert-rechten nach Artikel 973d OR ausgeben und als Bucheffekten f&uuml;hren lassen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Within the legal framework, the Company is free to convert its shares issued in one of these forms into another form at any time and without the consent of the shareholders, and to withdraw shares held as intermediated securities from the custody system. It shall bear the costs thereof.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Gesellschaft steht es im Rahmen der gesetzlichen Vorgaben frei, ihre in einer dieser Formen ausgegebenen Aktien jederzeit und ohne Zustimmung der Aktion&auml;re in eine andere Form umzuwandeln sowie als Bucheffekten gef&uuml;hrte Aktien aus dem Verwahrungssystem zur&uuml;ckzuziehen. Sie tr&auml;gt daf&uuml;r die Kosten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The shareholder shall not be entitled to the certification of membership rights in the form of physical securities or to the conversion of shares issued in a certain form into another form. However, the shareholder may at any time request the Company to issue a written confirmation of the shares held by him in accordance with the share register.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Aktion&auml;r hat keinen Anspruch auf wertpapierm&auml;ssige Verbriefung der Mitgliedschaftsrechte oder auf Umwandlung von in bestimmter Form ausgegebenen Aktien in eine andere Form. Der Aktion&auml;r kann jedoch von der Gesellschaft jederzeit die Ausstellung einer schriftlichen Bescheinigung &uuml;ber die von ihm gem&auml;ss Aktienbuch gehaltenen Aktien verlangen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The transfer of simple uncertificated securities pursuant to article 973c CO and registered uncertificated securities pursuant to article 973d CO as well as the provision of security for such uncertificated securities shall be governed by the provisions of the CO.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die &Uuml;bertragung von einfachen Wertrechten nach Artikel 973c OR und Registerwertrechten nach Artikel 973d OR sowie die Bestellung von Sicherheiten an diesen Wert-rechten richten sich nach den Bestimmungen des OR.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The transfer of intermediated securities and the provision of security for such intermediated securities shall be governed by the provisions of the Swiss Intermediated Securities Act.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die &Uuml;bertragung von Bucheffekten und die Bestellung von Sicherheiten an diesen Bucheffekten richten sich nach den Bestimmungen des Bucheffektengesetzes.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 7	Exercise of Shareholders Rights</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 7	Aus&uuml;bung von Aktion&auml;rsrechten</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">16</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The shares are indivisible and the Company recognizes only one single representative per share.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Aktien sind unteilbar und die Gesellschaft anerkennt nur einen einzigen Vertreter pro Aktie.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The right to vote and the other rights pertaining to a registered share may only be exercised by a shareholder, an usufructuary or a nominee who is registered with the right to vote in the share register and by persons who are entitled by law to the voting rights of a share.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Stimmrecht und die anderen zu einer Namenaktien geh&ouml;renden Rechte d&uuml;rfen nur von einem Aktion&auml;r, einem Nutzniesser oder Nominee, dessen Stimmrecht im Aktienregister eingetragen ist und von Personen, welchen kraft Gesetzes die Stimmrechte einer Aktie zustehen, ausge&uuml;bt werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.4pt;padding-left:39.4pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">III.	Corporate structure</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">III.	Organisation der Gesellschaft</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 8	Corporate Bodies</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The corporate bodies are:</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">A.	the General Meeting;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">B.	the Board of Directors;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">C.	the Auditors.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 8	Gliederung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaftsorgane sind:</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">A.	die Generalversammlung;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">B.	der Verwaltungsrat;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">C.	die Revisionsstelle.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.4pt;padding-left:39.4pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">IV.	General Meeting</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">IV.	Generalversammlung</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 9	Powers</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The General Meeting is the supreme body of the Company. It has the following non delegable powers:</font></p><div style="margin-left:0.050000000000000044in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.3553803871825076%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to adopt and amend the articles of association (articles 652g, 653g und 653i CO remain reserved);</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to elect and remove the members of the Board of Directors, the Chairman of the Board of Directors, the members of the Compensation Committee, the Auditors and the Independent Proxy;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to approve the management report and the annual accounts and to determine the allocation of profits, in </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 9	Befugnisse</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oberstes Organ der Gesellschaft ist die Generalversammlung. Ihr stehen folgende un&uuml;bertragbare Befugnisse zu:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Festsetzung und &Auml;nderung der Statuten (Artikel 652g, 653g und 653i OR bleiben vorbehalten);</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Wahl und Abberufung der Mitglieder des Verwaltungsrats, des Pr&auml;sidenten des Verwaltungsrats, der Mitglieder des Verg&uuml;tungsausschusses, der Revisionsstelle und des unabh&auml;ngigen Stimmrechtsvertreters;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Genehmigung des Lageberichts und der Jahresrechnung sowie Beschlussfassung &uuml;ber die Verwendung des Bilanzgewinnes, </font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">17</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">particular with regard to dividends and bonus payments;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to determine the interim dividend and the approval of the required interim financial statements;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to make a resolution on the repayment of the statutory capital reserve;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to discharge the members of the Board of Directors and of the Executive Committee;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">delisting of the Company's equity securities;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to approve the total compensation paid to the Board of Directors and the Executive Committee as per article 34 and article 35 below;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to pass resolutions concerning all matters which are reserved to the authority of the General Meeting by law or by the articles of association.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:25.2pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">insbesondere die Festsetzung der Dividende und der Tantieme;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Festsetzung der Zwischendividende und Genehmigung des daf&uuml;r erforderlichen Zwischenabschlusses;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Beschlussfassung &uuml;ber die R&uuml;ckzahlung der gesetzlichen Kapitalreserve;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Entlastung der Mitglieder des Verwaltungsrates und der Gesch&auml;ftsleitung;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Dekotierung der Beteiligungspapiere der Gesellschaft;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Genehmigung der Gesamtverg&uuml;tungen des Verwaltungsrats und der Gesch&auml;ftsleitung nach Massgabe von Artikel 34 und Artikel 35 hiernach;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Beschlussfassung &uuml;ber die Gegenst&auml;nde, die der Generalversammlung durch das Gesetz oder die Statuten vorbehalten sind.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 10	Ordinary General Meeting</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Ordinary General Meeting shall be held annually within six months after the end of the business year at such time and at such location, which may be within or outside Switzerland, as determined by the Board of Directors.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 10	Ordentliche Generalversammlung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die ordentliche Generalversammlung findet j&auml;hrlich innerhalb von sechs Monaten nach Abschluss des Gesch&auml;ftsjahres statt, zum Zeitpunkt und an einem Ort, der innerhalb oder ausserhalb der Schweiz sein kann, gem&auml;ss Festlegung durch den Verwaltungsrat.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">18</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 11	Extraordinary General Meeting<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Extraordinary General Meetings may be called by resolution of the General Meeting, the Auditors or the Board of Directors, or by shareholders with voting powers, provided they represent at least 5% of the share capital and who submit (a)(1) a request signed by such shareholder(s) that specifies the item(s) to be included on the agenda, (2) the respective proposals of the shareholders and (3) evidence of the required shareholdings recorded in the share register and (b) such other information as would be required to be included in a proxy statement pursuant to the rules of the country where the Company's shares are primarily listed.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 11	Ausserordentliche Generalversammlung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ausserordentliche Generalversammlungen k&ouml;nnen einberufen werden durch Beschluss der ordentlichen Generalversammlung, durch die Revisionsstelle oder den Verwaltungsrat oder</font><font style="color:#222222;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">durch stimmberechtigte Aktion&auml;re, sofern sie mindestens 5% des Aktienkapitals erreichen und die Folgendes einreichen: (a)(1) einen unterschriebenen Antrag dieser Aktion&auml;re, welcher die Traktanden angibt, die auf die Traktandenliste gesetzt werden, (2) die entsprechenden Antr&auml;ge der Aktion&auml;re und (3) den Nachweis der erforderlichen Beteiligung dieser Aktion&auml;re aufgrund des Aktienregisters und (b) alle anderen Informationen, die f&uuml;r eine Vollmacht nach den Regeln des Landes, in welchem die Aktien des Unternehmens haupts&auml;chlich eingetragen sind, erforderlich w&auml;ren.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:70.9pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:-70.9pt;padding-left:70.9pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 12	Notice and Agenda of Shareholders' Meetings</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Notice of a General Meeting of Shareholders shall be given by the Board of Directors or, if necessary, by the Auditor, not later than 20 calendar days prior to the date of the General Meeting of Shareholders. Notice of the General Meeting of Shareholders shall be given by way of a one-time announcement in the official means of publication of the Company pursuant to article 48 of these articles of association. The notice period shall be deemed to have been observed if notice of the General Meeting of Shareholders is published in such official means of publication, it being understood that the date of publication shall not be computed in the notice period. Shareholders of record may in addition be informed of the General Meeting of Shareholders by ordinary mail or e-mail.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 12	Mitteilung und Traktanden der Generalversammlung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Mitteilung einer Generalversammlung erfolgt durch den Verwaltungsrat oder gegebenenfalls durch die Revisionsstelle, sp&auml;testens 20 Kalendertage vor dem Datum der Generalversammlung. Die Mitteilung der Generalversammlung erfolgt durch eine einmalige Bekanntmachung in den amtlichen Publikationsmitteln der Gesellschaft gem&auml;ss Artikel 48 dieser Statuten. Die Frist gilt als eingehalten, wenn Ank&uuml;ndigung der Generalversammlung im offiziellen Publikationsmittel ver&ouml;ffentlicht wurde, wobei das Datum der Ver&ouml;ffentlichung nicht in die Mitteilungsfrist eingerechnet werden darf. Eingetragene Aktion&auml;re k&ouml;nnen zus&auml;tzlich per Post oder E-Mail &uuml;ber die Generalversammlung informiert werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The convocation of an extraordinary general meeting may also be requested in</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Einberufung einer ausserordentlichen Generalversammlung kann auch von einem oder</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">19</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">writing, indicating the agenda items and the proposals and, in case of elections, the names of the nominated candidates, by one or more shareholders together representing at least 5% of the share capital or the voting rights.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">mehreren Aktion&auml;ren, die zusammen mindestens 5% des Aktienkapitals oder der Stimmen vertreten, schriftlich unter Angabe des Verhandlungsgegenstandes und des Antrages, bei Wahlen der Namen der vorgeschlagenen Kandidaten, verlangt werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall state the matters on the agenda.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat setzt die Verhandlungsgegenst&auml;nde auf die Traktandenliste.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The notice of a General Meeting of Shareholders shall specify the items on the agenda and the proposals of the Board of Directors and the shareholder(s) who requested that a General Meeting of Shareholders be held or an item be included on the agenda, and, in the event of elections, the name(s) of the candidate(s) that has or have been put on the ballot for election.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Mitteilung der Genrealversammlung hat die Traktanden und die Antr&auml;ge des Verwaltungsrates und der Aktion&auml;re, welche beantragt haben, dass eine Generalversammlung abgehalten werden oder ein Traktandum auf die Traktandenliste gesetzt werden soll zu enthalten sowie, im Falle von Wahlen, die Namen der Kandidaten, welche auf den Wahlzettel gesetzt wurden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholders, together representing more than 0.5% of the share capital or the voting rights, may demand that an item be placed on the agenda. Such request must be made in writing at least 70 days prior to the meeting by indicating the agenda items and the proposals.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Aktion&auml;re, die zusammen mindestens &uuml;ber 0.5% des Aktienkapitals oder der Stimmen vertreten, k&ouml;nnen die Traktandierung eines Verhandlungsgegenstandes verlangen. Dies hat mindestens 70 Tage vor der Versammlung schriftlich unter Angabe der Verhandlungsgegenst&auml;nde und Antr&auml;ge zu erfolgen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each request for inclusion of an item on the agenda must include (i) a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting; (ii) the name and address, as they appear on the Company's register of shareholders, of the shareholder proposing such business; (iii) the number of shares of the Company which are beneficially owned by such shareholder; (iv) the dates upon which the shareholder acquired such shares; (v) documentary support for any claim of beneficial ownership; (vi) any material interest of such shareholder in such business; and (vii) a statement in support of the matter and, for proposals sought to be included in the Company's proxy statement, any</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jeder Antrag auf Aufnahme eines Traktandums hat zu enthalten: (i) eine kurze Zusammenfassung des Gesch&auml;fts, welches der Generalversammlung vorgelegt werden soll, sowie eine Begr&uuml;ndung, weshalb an der Versammlung dar&uuml;ber entschieden werden soll; (ii) den Namen und die Adresse des Gesuchstellenden Aktion&auml;rs, wie sie im Aktienbuch der Gesellschaft eingetragen sind; (iii) die Anzahl Aktien der Gesellschaft, die in der wirtschaftlichen Berechtigung des Aktion&auml;rs stehen; (iv) die Daten, an denen der Aktion&auml;r seine Aktien erworben hat; (v) erforderliche Nachweise bei allf&auml;lligen Anspr&uuml;chen von wirtschaftlicher Berechtigung; (vi) jegliches materielle Interesse des Aktion&auml;rs im Zusammenhang mit diesem Gesch&auml;ft; und (vii) eine Stellungnahme zum fraglichen Punkt und, f&uuml;r Antr&auml;ge, welche der Aktion&auml;rsinformation durch die Gesellschaft beigef&uuml;gt werden sollen, jede andere Information, welche die</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">20</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">other information required by Securities and Exchange Commission Rule &#34;14a-8&#34;.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Securities and Exchange Commission Rule &#34;14a-8&#34; verlangt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">In addition, if the shareholder intends to solicit proxies from the shareholders of the Company, such shareholder shall notify the Company of this intent in accordance with Securities and Exchange Commission Rule &#34;14a-4&#34; and/or Rule &#34;14a-8&#34;.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">F&uuml;r den Fall, dass ein Aktion&auml;r gedenkt, die Stimmrechtsvertretung von anderen Aktion&auml;ren der Gesellschaft zu erlangen, hat dieser Aktion&auml;r die Gesellschaft &uuml;ber diese Absicht gem&auml;ss der Securities and Exchange Commission Rule &#34;14a-4&#34; und/oder Rule &#34;14a-8&#34; zu informieren.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">No resolution may be passed at a General Meeting of Shareholders concerning an item in relation to which due notice was not given. Proposals made during a General Meeting of Shareholders to (i) convene a extraordinary General Meeting or (ii) initiate a special investigation in accordance with article 697a of the Swiss Code of Obligations are not subject to the due notice requirement set forth herein.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">An der Generalversammlung darf kein Beschluss &uuml;ber ein Traktandum getroffen werden, &uuml;ber den nicht mit entsprechender Vorlaufzeit informiert worden ist. Antr&auml;ge, die w&auml;hrend der Generalversammlung gestellt werden, f&uuml;hren zu (i) einer ausserordentlichen Generalversammlung oder (ii) einer speziellen Untersuchung gem&auml;ss Artikel 697a OR und unterliegen nicht der hierin geforderten Voraussetzung der rechtzeitigen Information.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">No advance notice is required to propose motions on duly notified agenda items and to debate items without passing resolutions.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zur Stellung von Antr&auml;gen im Rahmen der Verhandlungsgegenst&auml;nde und zu Ver-handlungen ohne Beschlussfassung bedarf es keiner vorherigen Ank&uuml;ndigung.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 13	Documentation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The annual business report, the compensation report and the Auditor's report must be submitted for examination by the shareholders at the registered office of the Company at least 20 days prior to the date of the Ordinary General Meeting. Each shareholder may request that a copy of this documentation be sent to him promptly. Such reference shall be included in the invitation to the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 13	Unterlagen</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Sp&auml;testens zwanzig Tage vor der ordentlichen Generalversammlung sind der Gesch&auml;ftsbericht, der Verg&uuml;tungsbericht und der Revisionsbericht am Sitz der Gesellschaft zur Einsicht der Aktion&auml;re aufzulegen. Jeder Aktion&auml;r kann verlangen, dass ihm unverz&uuml;glich eine Kopie dieser Unterlagen zugestellt wird. In der Einberufung zur Generalversammlung ist hierauf hinzuweisen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:70.9pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:-70.9pt;padding-left:70.9pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 14 	Form of the General Meeting</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:70.9pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:-70.9pt;padding-left:70.9pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 14 	Form der Generalversammlung</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors determines the location of the General Meeting. It may be abroad.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat bestimmt den Ort der Generalversammlung. Er kann im Ausland liegen.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">21</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors may provide that shareholders who are not present at the venue of the General Meeting may exercise their rights electronically (hybrid General Meeting).</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat kann vorsehen, dass Aktion&auml;re, die nicht am Ort der Generalversammlung anwesend sind, ihre Rechte auf elektronischem Weg aus&uuml;ben k&ouml;nnen (hybride Generalversammlung).</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">A General Meeting may be held by electronic means without a meeting place (Virtual General Meeting).</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Eine Generalversammlung kann mit elektronischen Mitteln ohne Tagungsort durchgef&uuml;hrt werden (virtuelle Generalversammlung).</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">22</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors regulates the use of electronic means. It shall ensure that:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.3597222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.796%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the identity of the participants is established; and</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.3597222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.796%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the votes at the General Meeting are transmitted directly; and</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.3597222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.796%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">each participant can submit motions and take part in the discussion; and</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.3597222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.796%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the voting results cannot be falsified.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat regelt die Verwendung elektronischer Mittel. Er stellt sicher, dass:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.3597222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.796%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Identit&auml;t der Teilnehmer feststeht;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Voten in der Generalversammlung unmittelbar &uuml;bertragen werden;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">jeder Teilnehmer Antr&auml;ge stellen und sich an der Diskussion beteiligen kann; und</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">das Abstimmungsergebnis nicht verf&auml;lscht werden kann.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If technical problems occur during a Virtual General Meeting so that the General Meeting cannot be held properly, it must be repeated. Resolutions passed by the General Meeting before the occurrence of the technical problems shall remain valid.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Treten w&auml;hrend einer Generalversammlung mit elektronischen Mitteln technische Probleme auf, sodass die Generalversammlung nicht ordnungsgem&auml;ss durchgef&uuml;hrt werden kann, so muss sie wiederholt werden. Beschl&uuml;sse, welche die Generalversammlung vor dem Auftreten der technischen Probleme gefasst hat, bleiben g&uuml;ltig.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 15	Meeting of All Shareholders</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholders or their proxies representing all shares issued may hold a General Meeting without observing the formalities required for calling a meeting, unless objection is raised. At such a meeting, discussions may be held and resolutions passed on all matters within the scope of the powers of a General Meeting for so long as the shareholders or proxies representing all shares issued are present.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 15	Universalversammlung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Eigent&uuml;mer oder Vertreter s&auml;mtlicher Aktien k&ouml;nnen, falls kein Widerspruch erhoben wird, eine Generalversammlung ohne Einhaltung der f&uuml;r die Einberufung vorgeschriebenen Formvorschriften abhalten (Universalversammlung). Solange die Eigent&uuml;mer oder Vertreter s&auml;mtlicher Aktien anwesend sind, kann in dieser Versammlung &uuml;ber alle in den Gesch&auml;ftskreis der Generalversammlung fallenden Gegenst&auml;nde verhandelt und g&uuml;ltig Beschluss gefasst werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 16	Chairman, Secretary, Scrutineers</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Chairman of the Board of Directors shall preside over the General Meeting. In his absence, a member of the Board of Directors or another Chairman of the Meeting designated by the General Meeting shall preside.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 16	Vorsitz, Protokollf&uuml;hrer, Stimmenz&auml;hler</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Den Vorsitz der Generalversammlung f&uuml;hrt der Pr&auml;sident, bei dessen Verhinderung ein anderes Mitglied des Verwaltungsrates oder ein anderer von der Generalversammlung gew&auml;hlter Tagespr&auml;sident.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Chairman of the Meeting shall designate a Secretary and the scrutineers who need not be shareholders.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Vorsitzende bezeichnet den Protokollf&uuml;hrer und die Stimmenz&auml;hler, die nicht Aktion&auml;re zu sein brauchen.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">23</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Chairman shall have all powers and authority necessary to ensure the orderly conduct of the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Vorsitzende hat s&auml;mtliche Leitungsbefugnisse, die f&uuml;r die ordnungsgem&auml;sse Durchf&uuml;hrung der Generalversammlung n&ouml;tig sind.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 17	Minutes</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors is responsible for the keeping of the minutes of the Meeting, which shall state the number, kind, nominal value of shares represented by the shareholders, by the corporate bodies and by the independent proxy and gives information on resolutions passed, elections, requests for information and information as well as declarations given by the shareholders. The minutes shall be signed by the Chairman and the Secretary.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 17	Protokoll</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat sorgt f&uuml;r die F&uuml;hrung des Protokolls &uuml;ber die Generalversammlung, welches Anzahl, Art, Nennwert und Kategorie der von den Aktion&auml;ren, von den Organen und von unabh&auml;ngigen Stimmrechtsvertretern vertretene Aktien festh&auml;lt und Aufschluss &uuml;ber Beschl&uuml;sse, Wahlergebnisse, Begehren um Auskunft und die darauf erteilten Ausk&uuml;nfte sowie die von den Aktion&auml;ren zu Protokoll gegebenen Erkl&auml;rungen gibt. Das Protokoll wird vom Vorsitzenden und vom Protokollf&uuml;hrer unterzeichnet.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The shareholders are entitled to inspect the minutes.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Aktion&auml;re sind berechtigt, das Protokoll einzusehen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 18	Right to Vote</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each share entitles to one vote.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each shareholder may be represented at a General Meeting by any person who is so authorized by a written proxy. A proxy need not be a shareholder.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 18	Stimmrecht</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jede Aktie berechtigt zu einer Stimme.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jeder Aktion&auml;r kann sich in der Generalversammlung aufgrund einer schriftlichen Vollmacht durch eine andere handlungsf&auml;hige Person vertreten lassen, die nicht Aktion&auml;r zu sein braucht.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each shareholder may be represented by the Independent Proxy. The requirements regarding proxies and instructions are determined by the Board of Directors.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jeder Aktion&auml;r kann sich vom unabh&auml;ngigen Stimmrechtsvertreter vertreten lassen. Die Anforderungen an Vollmachten und Weisungen werden vom Verwaltungsrat festgelegt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 19	Resolutions and Elections</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">All voting and elections are held openly or electronically. A written voting or election shall be held if instructed so by the Chairman or if decided by the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 19	Beschlussfassung und Wahlen</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Abstimmungen und Wahlen erfolgen offen oder elektronisch. Eine schriftliche Abstimmung oder Wahl wird durchgef&uuml;hrt, wenn dies vom Vorsitzenden angeordnet oder von der Generalversammlung beschlossen wird.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The General Meeting shall pass its resolutions and carry out its elections with the simple majority of the votes cast regardless of abstentions and empty or invalid votes, unless law or articles of association state otherwise. In the event</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Generalversammlung fasst ihre Beschl&uuml;sse und vollzieht ihre Wahlen, soweit das Gesetz oder die Statuten es nicht anders bestimmen, mit der einfachen Mehrheit der abgegebenen Aktienstimmen ohne Ber&uuml;cksichtigung von Stimmenthaltungen oder leer eingelegten oder ung&uuml;ltigen Stimmen. Bei</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">24</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">of tie votes, the request shall be refused. The Chairman shall not have a casting vote.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Stimmengleichheit gilt ein Antrag als abgelehnt. Dem Vorsitzenden steht kein Stichentscheid zu.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">A resolution of the General Meeting passed by at least two thirds of the represented share votes and the absolute majority of the represented shares par value is required for:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The cases listed in article 704 para. 1 CO:</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the amendment of the purpose of the Company;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the consolidation of shares, insofar as this does not require the consent of all shareholders concerned;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the increase of the share capital against contributions in kind or by offsetting against a receivable and the granting of special benefits;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the limitation or withdrawal of subscription rights;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">v.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the introduction of conditional capital, the creation of reserve capital pursuant to article 12 of the Swiss Banking Act or the introduction of a capital band;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">vi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the conversion of participation certificates into shares;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">vii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the restriction of the transferability of registered shares;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">viii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the creation of shares with privileged voting rights;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">ix.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the change of currency of the share capital;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">x.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the introduction of the casting vote of the chairman in the general assembly;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">xi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the introduction of a provision in </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ein Beschluss der Generalversammlung, durch mindestens zwei Drittel der vertretenen Aktienstimmen und die absolute Mehrheit der vertretenen Aktiennennwerte, ist erforderlich f&uuml;r:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die F&auml;lle gem&auml;ss Artikel 704 Abs. 1 OR:</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die &Auml;nderung des Gesellschaftszweckes;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Zusammenlegung von Aktien, soweit daf&uuml;r nicht die Zustimmung aller betroffenen Aktion&auml;re erforderlich ist;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Kapitalerh&ouml;hung aus Eigenkapital, gegen Sacheinlagen oder durch Verrechnung mit einer Forderung und die Gew&auml;hrung von besonderen Vorteilen;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Einschr&auml;nkung oder Aufhebung des Bezugsrechts;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">v.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Einf&uuml;hrung eines bedingten Kapitals, die Schaffung von Vorratskapital gem&auml;ss Artikel 12 des Bankengesetzes oder die Einf&uuml;hrung eines Kapitalbands;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">vi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Umwandlung von Partizipationsscheinen in Aktien;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">vii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Beschr&auml;nkung der &Uuml;bertragbarkeit von Namenaktien;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">viii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Einf&uuml;hrung von Stimmrechtsaktien;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">ix.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">der Wechsel der W&auml;hrung des Aktienkapitals;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">x.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Einf&uuml;hrung des Stichentscheids des Vorsitzenden in der Generalversammlung;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">xi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine Statutenbestimmung zur Durchf&uuml;hrung der Generalversammlung im Ausland;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">xii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Verletzung des Sitzes der Gesellschaft;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="margin-left:0.42986111111111114in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;display:inline-flex;justify-content:flex-start;">xiii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Einf&uuml;hrung einer statutarischen Schiedsklausel;</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">25</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the articles of association to hold General Meetings abroad;</font></div></div><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the change of the registered office of the Company;</font></div></div><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xiii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the introduction of an arbitration clause in the articles of association;</font></div></div><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xiv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the delisting of the shares; or</font></div></div><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the dissolution of the Company.</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the merger, de-merger or conversion of the Company (subject to mandatory law);	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the alleviating or withdrawal of restrictions upon the transfer of registered shares;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the conversion of registered shares into bearer shares and vice versa; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the amendment or elimination of the provisions of articles 4 and 31 of the articles of association as well as those contained in this article 19.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xiv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Dekotierung der Beteiligungspapiere; oder</font></div></div><div style="margin-left:0.42986111111111114in;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.12013888888888889in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:1.6993921649747%;text-indent:0;display:inline-flex;justify-content:flex-start;">xv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Aufl&ouml;sung der Gesellschaft.</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Fusion, Spaltung oder Umwandlung der Gesellschaft (vorbehalten zwingender gesetzlicher Bestimmungen);</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Erleichterung oder den Entzug der Beschr&auml;nkungen betreffend die &Uuml;bertragung von Namenaktien;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Umwandlung von Namenaktien in Inhaberaktien und umgekehrt; und</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die &Auml;nderung oder Aufhebung der Bestimmungen der Artikel 4 und 31 der Statuten sowie dieses Artikels 19.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 20	Votes on Compensation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each year, the General Meeting approves in one or separate resolutions the total maximum amounts pursuant to articles 34 and 35 of the articles of association for:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the non-performance-related compensation of the Board of Directors for the next term of office;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a possible additional compensation of the Board of Directors for the preceding business year;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the non-performance-related compensation of the Executive Committee for the following business year;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the variable compensation for the </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 20	Abstimmung &uuml;ber Verg&uuml;tungen</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Generalversammlung genehmigt j&auml;hrlich in einem oder mehreren Beschl&uuml;ssen die maximalen Verg&uuml;tungen gem&auml;ss Artikel 34 und 35 der Statuten betreffend:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die nicht-erfolgsabh&auml;ngige Verg&uuml;tung des Verwaltungsrates f&uuml;r die Zeitperiode bis zur n&auml;chsten Generalversammlung;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine allf&auml;llige zus&auml;tzliche Verg&uuml;tung f&uuml;r den Verwaltungsrat f&uuml;r das abgeschlossene Gesch&auml;ftsjahr;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die nicht-erfolgsabh&auml;ngige Verg&uuml;tung der Gesch&auml;ftsleitung f&uuml;r das folgende Gesch&auml;ftsjahr;<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die variable Verg&uuml;tung der Gesch&auml;ftsleitung f&uuml;r das folgende Gesch&auml;ftsjahr; und</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">26</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Executive Committee for the following business year; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the grant of options, shares or other equity-linked instruments in the Company to the Board of Directors and the Executive Committee.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:25.2pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri Light;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">die Gew&auml;hrung von Optionen, Aktien oder anderen eigenkapitalbasierten Instrumenten der Gesellschaft an den Verwaltungsrat oder die Gesch&auml;ftsleitung.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The corresponding total compensation includes all social security, pension fund and other contributions payable by the receiving member of the Board of Directors or the Executive Board.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die entsprechenden Gesamtverg&uuml;tungen umfassen alle vom empfangenden Mitglied des Verwaltungsrats oder der Gesch&auml;ftsleitung zu bezahlenden Sozialversicherungs-, Pensionskassen- und andere Beitr&auml;ge.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If the General Meeting refuses to approve a respective motion by the Board of Directors, the Board of Directors may either submit a new motion at the same meeting or determine a maximum total remuneration or several maximum partial remunerations, subject to the relevant principles of the compensation, or submit a new motion to the next General Meeting for approval. The Company may pay remunerations within the framework of the maximum total or partial remuneration and subject to the approval by the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Lehnt die Generalversammlung einen entsprechenden Antrag des Verwaltungsrats ab, kann der Verwaltungsrat entweder an der gleichen Versammlung einen neuen Antrag stellen, eine ausserordentliche Generalversammlung einberufen oder einen maximalen Gesamtbetrag oder mehrere maximale Teilbetr&auml;ge unter Ber&uuml;cksichtigung der relevanten Grunds&auml;tze festsetzen und der n&auml;chsten Generalversammlung zur Genehmigung vorlegen. Die Gesellschaft kann im Rahmen des maximalen Gesamt- oder Teilbetrages und unter Vorbehalt der Genehmigung durch die Generalversammlung Verg&uuml;tungen ausrichten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 21	Independent Proxy</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Independent Proxy shall be elected by the Ordinary General Meeting for a term of one year until the end of the next Ordinary General Meeting. Re-election is permitted. The Independent Proxy informs the Company about number, type, par value and category of the represented shares. The Chairman of the Board discloses the information to the General Meeting. The other duties of the Independent Proxy are determined by the applicable statutory provisions.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 21	Unabh&auml;ngiger Stimmrechtsvertreter</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Unabh&auml;ngige Stimmrechtsvertreter wird von der ordentlichen Generalversammlung f&uuml;r eine Amtsdauer von einem Jahr bis zum Ende der n&auml;chsten ordentlichen Generalversammlung gew&auml;hlt. Wiederwahl ist m&ouml;glich. Der unabh&auml;ngige Stimmrechtsvertreter informiert die Gesellschaft &uuml;ber Anzahl, Art, Nennwert und Kategorie der vertretenen Aktien. Der Pr&auml;sident des Verwaltungsrats gibt diese Informationen der Generalversammlung bekannt. Die Pflichten des Unabh&auml;ngigen Stimmrechtsvertreters ergeben sich aus den anwendbaren gesetzlichen Bestimmungen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">V.	Board of directors</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">V.	Verwaltungsrat</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">27</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 22	Number of Members, Term of Office</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall consist of at least 3 and not more than 9 members. The chairman and the members of the Board of Directors are individually elected by the General Meeting for a term of one year until the end of the next Ordinary General Meeting, provided that he/she does not resign or is not replaced during his term.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 22	Anzahl der Mitglieder, Amtsdauer</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat besteht aus mindestens 3 und h&ouml;chstens 9 Mitgliedern. Der Pr&auml;sident sowie die Mitglieder des Verwaltungsrates werden jeweils f&uuml;r die Dauer von einem Jahr bis zum Ende der n&auml;chsten ordentlichen Generalversammlung einzeln gew&auml;hlt. Vorbehalten bleiben vorheriger R&uuml;cktritt oder Abberufung.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The members of the Board of Directors may be re-elected without limitation. The maximum age limit of members of the Board shall be 75 years. When a member of the Board of Directors reaches this age limit during his term of office, such term shall automatically extend to the next ordinary shareholders' meeting. The shareholders' meeting may resolve to grant an exception to the age limit.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Mitglieder des Verwaltungsrates sind jederzeit wieder w&auml;hlbar. Die oberste Altersgrenze von Mitgliedern des Verwaltungsrats betr&auml;gt 75 Jahre. Wenn ein Mitglied des Verwaltungsrats diese Altersgrenze w&auml;hrend seiner Amtszeit erreicht, wird diese automatisch zur n&auml;chsten ordentlichen Generalversammlung verl&auml;ngert. Die Generalversammlung kann eine Ausnahme von der Altersgrenze beschliessen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If the office of the Chairman becomes vacant, the board of directors shall appoint a new Chairman, from among its members for the remaining term of office.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Wird das Amt des Pr&auml;sidenten vakant, ernennt der Verwaltungsrat f&uuml;r die verbleibende Amtsdauer aus seiner Mitte einen neuen Pr&auml;sidenten des Verwaltungsrates f&uuml;r die verbleibende Amtszeit.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 23	Constitution</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Subject to the powers of the General Meeting, the Board of Directors determines its own organization. It appoints a Secretary who needs not be a member of the Board of Directors.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 23	Konstituierung</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat konstituiert sich vorbeh&auml;ltlich der Befugnisse der Generalversammlung selbst. Er bezeichnet insbesondere einen Sekret&auml;r, der nicht Mitglied des Verwaltungsrates sein muss.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 24	Function, Organization</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">It is the Board of Director's duty to lead the Company and to supervise the management. The Board of Director represents the Company and may take decisions to all affairs which are not assigned to any other body of the Company by law, the articles of association or Regulations.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 24	Funktion, Organisation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Dem Verwaltungsrat obliegt die oberste Leitung der Gesellschaft und die &Uuml;berwachung der Gesch&auml;ftsf&uuml;hrung. Er vertritt die Gesellschaft nach aussen und besorgt alle Angelegenheiten, die nicht nach Gesetz, Statuten oder Reglement einem anderen Organ der Gesellschaft &uuml;bertragen sind.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">28</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall adopt the organizational regulations and the corresponding contractual relationships.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat erl&auml;sst das Organisationsreglement und ordnet die entsprechenden Vertragsverh&auml;ltnisse.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 25	Powers</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors has the following non-delegable and inalienable duties:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the overall management of the company and the issuing of all necessary directives;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the determination of the company's organisation;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the organisation of the accounting, financial control and financial planning systems as required for management of the company;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the appointment and dismissal of the persons entrusted with the management and representation of the Company and grant of signatures;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the overall supervision of the persons entrusted with managing the company, in particular with regard to compliance with the law, articles of association, operational regulations and directives;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the compilation of the annual report, preparation for the general meeting and implementation of its resolutions;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the preparation of the compensation report and to request approval by the General Meeting regarding compensation of the Board of Directors and the Executive Committee; and</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the notification of the court if liabilities exceed assets.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 25	Aufgaben</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat hat folgende un&uuml;bertragbare und unentziehbare Aufgaben:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oberleitung der Gesellschaft und Erteilung der n&ouml;tigen Weisungen;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Festlegung der Organisation der Gesellschaft;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Organisation des Rechnungswesens, der Finanzkontrolle sowie der Finanzplanung zur F&uuml;hrung der Gesellschaft;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ernennung und Abberufung der mit der Gesch&auml;ftsf&uuml;hrung und der Vertretung betrauten Personen und Regelung der Zeichnungsberechtigung;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Oberaufsicht &uuml;ber die mit der Gesch&auml;ftsf&uuml;hrung betrauten Personen, namentlich im Hinblick auf die Befolgung der Gesetze, Statuten, Reglemente und Weisungen;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erstellung des Gesch&auml;ftsberichtes sowie Vorbereitung der Generalversammlung und Ausf&uuml;hrung ihrer Beschl&uuml;sse;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erstellung des Verg&uuml;tungsberichts sowie Antragsstellung betreffend die Genehmigung der Verg&uuml;tungen des Verwaltungsrats und der Gesch&auml;ftsleitung an die Generalversammlung;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Benachrichtigung des Richters im Falle der &Uuml;berschuldung.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors may assign responsibility for preparing and implementing its resolutions or monitoring transactions to committees or</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat kann die Vorbereitung und die Ausf&uuml;hrung seiner Beschl&uuml;sse oder die &Uuml;berwachung von Gesch&auml;ften Aussch&uuml;ssen oder einzelnen</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">29</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">individual members. It must ensure appropriate reporting to its members.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mitgliedern zuweisen. Er hat f&uuml;r eine angemessene Berichterstattung an seine Mitglieder zu sorgen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 26	Representation of the Company</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall assign the persons with signatory power for the Company and the kind of signatory power.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 26	Vertretung der Gesellschaft</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat bestimmt die f&uuml;r die Gesellschaft zeichnungsberechtigten Personen und die Art ihrer Zeichnung.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 27	Delegation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Moreover, the Board of Directors is authorized to delegate, in part or entirely, the management and the representation of the Company, within the limits of the law, to one or more individual directors (Delegates) or to third parties by pursuant to organizational regulations.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 27	Delegation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat kann die Gesch&auml;ftsf&uuml;hrung und alle Aufgaben und Befugnisse, die ihm nicht durch das Gesetz oder die Statuten zwingend zugewiesen sind, nach Massgabe des Organisationsreglements ganz oder zum Teil an einzelne oder mehrere Mitglieder oder Dritte &uuml;bertragen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 28	Meetings, Resolutions and Minutes</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The organization of the meetings, the presence quorum and the passing of resolutions of the Board of Directors is determined by the organizational regulations. No presence quorum is required for the approval of a capital increase.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 28	Sitzungen, Beschlussfassung und Protokoll</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Sitzungsordnung, Beschlussf&auml;higkeit und Beschlussfassung des Verwaltungsrats richten sich nach dem Organisationsreglement. F&uuml;r den Feststellungsbeschluss einer Kapitalerh&ouml;hung ist kein Pr&auml;senzquorum erforderlich.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Resolutions may be passed via telephone or videoconference. Resolutions may also be passed by way of circulation, provided that no member requests oral deliberation.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Beschlussfassung via Telefon- oder Videokonferenz ist zul&auml;ssig. Beschl&uuml;sse k&ouml;nnen auch auf dem Zirkularweg gefasst werden, sofern nicht ein Mitglied die Durchf&uuml;hrung einer Sitzung verlangt.</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Minutes are kept of the Board's discussions and resolutions and signed by the chairman and the minute-taker.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&Uuml;ber Verhandlungen und Beschl&uuml;sse des Verwaltungsrats wird ein Protokoll erstellt, welches vom</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Vorsitzenden und vom Sekret&auml;r des Verwaltungsrates zu unterzeichnen ist.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 29	Disclosure and Right of Inspection</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Any member of the Board of Directors may request information on any company business.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 29	Recht auf Auskunft und Einsicht</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jedes Mitglied des Verwaltungsrates kann Auskunft &uuml;ber alle Angelegenheiten der Gesellschaft verlangen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Outside meetings, any member may request information from the persons</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ausserhalb der Sitzungen kann jedes Mitglied von den mit der Gesch&auml;ftsf&uuml;hrung betrauten Personen</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">30</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">entrusted with managing the company's business concerning the Company's business performance and, with the Chairman's authorization, specific transactions.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Auskunft &uuml;ber den Gesch&auml;ftsgang und, mit Erm&auml;chtigung des Pr&auml;sidenten, auch &uuml;ber einzelne Gesch&auml;fte verlangen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Where required for the performance of his duties, any member may request the Chairman to have books of account and documents made available to him for inspection.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Soweit es f&uuml;r die Erf&uuml;llung einer Aufgabe erforderlich ist, kann jedes Mitglied dem Pr&auml;sidenten beantragen, dass ihm B&uuml;cher und Akten vorgelegt werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If the Chairman refuses a request for information, a request to be heard or an application to inspect documents, the Board of Directors rules on the matter.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Weist der Pr&auml;sident ein Gesuch auf Auskunft, Anh&ouml;rung oder Einsicht ab, so entscheidet der Verwaltungsrat.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">31</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 30	Compensation Committee</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Compensation Committee shall comprise at least 2 members. The members of the Compensation Committee shall be individually elected by the Ordinary General Meeting from among the members of the Board of Directors for a term of one year until the next Ordinary General Meeting. Re-election is permitted. The Compensation Committee has the following duties:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to draw up principles for compensation of members of the Board of Directors and the Executive Committee and to submit them to the Board of Directors for approval;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to propose to the Board of Directors the resolution to be submitted to the Ordinary General Meeting for the maximum total compensation of the Board of Directors and Executive Committee;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">subject to and within the bounds of the maximum compensation approved by the Ordinary General Meeting, to request approval by the Board of Directors of the individual remuneration packages to be paid to members of the Board of Directors and members of the Executive Committee;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to request approval by the Board of Directors regarding the determination of the compensation-related targets for the Executive Committee;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to request approval by the Board of Directors regarding the adjustments to the articles of association relating to remuneration; and</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">to prepare the Compensation Report and submit it to the Board of </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 30	Verg&uuml;tungsausschuss</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verg&uuml;tungsausschuss umfasst mindestens 2 Mitglieder. Die Mitglieder des Verg&uuml;tungsausschusses werden j&auml;hrlich von der ordentlichen Generalversammlung aus den Mitgliedern des Verwaltungsrats f&uuml;r die Dauer von einem Jahr bis zur n&auml;chsten ordentlichen Generalversammlung einzeln gew&auml;hlt. Wiederwahl ist zul&auml;ssig. Der Verg&uuml;tungsausschuss hat folgende Aufgaben:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ausarbeiten der Grunds&auml;tze betreffend Verg&uuml;tung an den Verwaltungsrat und an die Gesch&auml;ftsleitung und Vorlegen derselben zur Genehmigung durch den Verwaltungsrat;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Antragstellung an den Verwaltungsrat zur Unterbreitung an die Generalversammlung betreffend Gesamtverg&uuml;tung des Verwaltungsrats und der Gesch&auml;ftsleitung;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Antragstellung an den Verwaltungsrat betreffend individuelle Verg&uuml;tung der Verwaltungsratsmitglieder und der Mitglieder der Gesch&auml;ftsleitung unter Vorbehalt und im Rahmen der H&ouml;he der Gesamtverg&uuml;tung;<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Antragstellung an den Verwaltungsrat hinsichtlich der f&uuml;r die Gesch&auml;ftsleitung verg&uuml;tungsrelevanten Ziele;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Antragstellung an den Verwaltungsrat betreffend Anpassung der Statuten hinsichtlich des Verg&uuml;tungssystems; und</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Entwurf des Verg&uuml;tungsberichts und Unterbreitung des Verg&uuml;tungsberichts an den Verwaltungsrat.</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">32</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Directors.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall set out any further duties and responsibilities vested on the Compensation Committee in the Company's organizational regulations.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat kann weitere Aufgaben und Zust&auml;ndigkeiten des Verg&uuml;tungsausschusses im Organisationsreglement vorsehen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 31	Indemnification</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 31	Schadloshaltung</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">To the extent not included in insurance cover-age or paid by third parties, the Company shall indemnify and hold harmless, to the extent permitted by law, the existing and former members of the board of directors, the executive committee, and their heirs, executors and administrators, out of the assets of the Company from and against all threatened, pending or completed actions, suits or proceedings &#x2013; whether civil, criminal, administrative or investigative &#x2013; and all costs, charges, losses, damages, and expenses which they or any of them, their heirs, executors or administrators, shall or may incur or sustain by or by reason of any actual or alleged actions, consents or omissions in or about the execution of their du-ty, or alleged duty, or by reason of the fact that he/she is or was a member of the board of di-rectors or executive committee of the Company or the board of directors (or equivalent corporate body) or the management of one of its subsidiaries, or, while serving as a member of the board of directors or executive committee of the Company, is or was serving at the re-quest of the Company as a director, member of the executive committee, employee or agent of another corporation, partnership, joint venture, trust or other enterprise; provided, however, that this indemnity shall not extend to any matter in which any of said persons is found, in a final judgment or decree of a court or governmental or administrative authority of competent jurisdiction not subject to appeal, to have committed an intentional</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Soweit nicht durch Versicherungen gedeckt oder von Dritten bezahlt, h&auml;lt die Gesellschaft soweit gesetzlich zul&auml;ssig, die gegenw&auml;rtigen und bisherigen Mitglieder des Verwaltungsrates und der Gesch&auml;ftsleitung sowie deren Erben, Testamentsvollstrecker und Verwalter aus dem Verm&ouml;gen der Gesellschaft von allen angedrohten, h&auml;ngigen, und abgeschlossenen Klagen, Prozessen oder Verfahren &#x2013; ob zivil-, straf-, verwaltungs- oder untersuchungsrechtlich &#x2013; schadlos, sowie von allen Kosten, Geb&uuml;hren, Verlusten, Sch&auml;den und Ausgaben, die ihnen oder einem/einer von ihnen, ihren Erben, Testamentsvollstreckern oder Verwaltern durch oder aufgrund von tats&auml;chlichen oder vermeintlichen Handlungen, Zustimmungen oder Unterlassungen im Zusammenhang mit der Aus&uuml;bung ihrer Pflicht oder vermeintlichen Pflicht oder aufgrund der Tatsache, dass er/sie ein Mitglied des Verwaltungsrates oder der Gesch&auml;ftsleitung der Gesellschaft oder des Verwaltungsrates (oder eines gleichwertigen Gesellschaftsorgans) oder der Gesch&auml;ftsleitung einer ihrer Konzerngesellschaften ist oder war, oder dass er/sie w&auml;hrend seiner/ihrer T&auml;tigkeit als Mitglied des Verwaltungsrates oder der Gesch&auml;ftsleitung der Gesellschaft, auf Ersuchen der Gesellschaft, als Mitglied des Verwaltungsrates oder der Gesch&auml;ftsleitung, Angestellter oder Beauftragter einer anderen Kapitalgesellschaft, Personengesellschaft, eines Joint Ventures, eines Trusts oder eines anderen Unternehmens t&auml;tig ist oder war, entstanden sind, entstehen oder entstehen k&ouml;nnten, jedoch unter der Voraussetzung, dass sich diese Schadloshaltung nicht auf eine Angelegenheit erstreckt, in der eine der genannten Personen gem&auml;ss einem rechtskr&auml;ftigen Urteil oder Beschluss eines Gerichts oder einer zust&auml;ndigen Regierungs- oder Verwaltungsbeh&ouml;rde, gegen den kein Rechtsmittel eingelegt werden kann, eine vors&auml;tzliche oder grobfahrl&auml;ssige Verletzung ihrer gesetzlichen Pflichten</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">33</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">or grossly negligent breach of his statutory duties as a member of the board of directors or executive committee.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">als Mitglied des Verwaltungsrates oder der Gesch&auml;ftsleitung begangen hat.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Without limiting the foregoing paragraph of this article 31, the Company shall advance costs and expenses indemnifiable thereunder to the existing and former members of the board of directors and executive committee to the ex-tent not included in insurance coverage or advanced by third parties. The Company may however recover such advanced costs if any of said persons is found, in a final judgment or decree of a court or governmental or administrative authority of competent jurisdiction not subject to appeal, to have committed an intentional or grossly negligent breach of his statutory duties as a member of the board of directors or executive committee.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ohne den vorstehenden Absatz dieses Artikels 31 einzuschr&auml;nken, hat die Gesellschaft den gegenw&auml;rtigen und ehemaligen Mitgliedern des Verwaltungsrates und der Gesch&auml;ftsleitung die Kosten und Auslagen zu erstatten, die nach diesem Artikel erstattungsf&auml;hig sind, soweit sie nicht durch Versicherungen gedeckt sind oder von Dritten vorab erstattet werden. Die Gesellschaft kann jedoch diese vorausbezahlten Konten zur&uuml;ckfordern, wenn eine der genannten Personen in einem rechtskr&auml;ftigen Urteil oder Beschluss eines Gerichts oder einer zu-st&auml;ndigen Regierungs- oder Verwaltungsbeh&ouml;rde, gegen das kein Rechtsmittel eingelegt werden kann, wegen vors&auml;tzlicher oder grob-fahrl&auml;ssiger Verletzung ihrer gesetzlichen Pflichten als Mitglied des Verwaltungsrates oder der Gesch&auml;ftsleitung verurteilt wird.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.4pt;padding-left:39.4pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">VI.	Auditors</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">VI.	Revisionsstelle</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 32	Election, Term</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The General Meeting shall elect one or more accountants as its Auditors in terms of articles 727 et seq. CO every year with the rights and duties determined by law.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 32	Wahl, Amtsdauer</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Generalversammlung w&auml;hlt jedes Jahr eine oder mehrere nat&uuml;rliche oder juristische Personen als Revisionsstelle im Sinne von Artikeln 727 ff. OR mit den im Gesetz festgehaltenen Rechten und Pflichten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The General Meeting may appoint Special Auditors for a term of up to three years who provide the attestations required for capital increases.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Generalversammlung kann f&uuml;r die Dauer von bis zu drei Jahren Sonderrevisoren bestimmen, welche die bei Kapitalerh&ouml;hungen erforderlichen Bescheinigungen erbringen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 33	Duties</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Auditors shall perform their duties to audit and report whether the accounting, the annual accounts and the proposal regarding allocation of profits is in accordance with law and the articles of association.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 33	Aufgaben</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Revisionsstelle pr&uuml;ft, ob die Buchf&uuml;hrung und die Jahresrechnung sowie der Antrag &uuml;ber die Verwendung des Bilanzgewinns Gesetz und Statuten entsprechen.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">34</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">VII.	compensation and related provisions</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">vii.	Verg&uuml;tungen und verwandte Bestimmungen</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 34	Principles of the Compensation of the Board of Directors</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The compensation payable to the members of the Board of Directors comprises, subject to and within the bounds of the approval by the General Meeting of the total compensation, the following elements:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a fixed basic remuneration;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a fixed committee fee for work in a committee of the Board of Directors; </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a lump sum compensation for expenses; </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a number of options, shares or other equity-linked instruments in the Company, as further outlined in article 43 of the articles of association.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 34	Grunds&auml;tze der Verg&uuml;tung f&uuml;r die Mitglieder des Verwaltungsrats</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Verg&uuml;tung f&uuml;r die Mitglieder des Verwaltungsrats umfasst, unter Vorbehalt der Genehmigung durch die Generalversammlung und im Rahmen der durch diese genehmigten Gesamtverg&uuml;tung, folgende Elemente:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">ein fixes Grundhonorar;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine fixe Entsch&auml;digung f&uuml;r T&auml;tigkeiten als Mitglied eines Ausschusses des Verwaltungsrats;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine pauschale Spesenentsch&auml;digung; </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine Anzahl von Optionen, Aktien oder anderen eigenkapitalbasierten Instrumenten der Gesellschaft, gem&auml;ss Artikel 43 der Statuten.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The compensation is paid in cash and in form of options, shares or other equity-linked instruments in the Company. The board of directors or, to the extent delegated to it, the Compensation Committee shall determine grant, exercise and forfeiture conditions. In particular, they may provide for continuation, acceleration or removal of vesting, exercise and forfeiture conditions, for payment or grant of compensation based upon assumed target achievement, or for forfeiture, in each case in the event of pre-determined events such as a change-of-control or termination of an employment or mandate agreement. The Company may procure the required shares through purchases in the market, from treasury</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Verg&uuml;tung kann bar und in Form von Optionen, Aktien oder anderen eigenkapitalbasierten Instrumenten der Gesellschaft bezahlt werden. Der Verwaltungsrat oder, soweit an ihn delegiert, der Verg&uuml;tungsausschuss legen Zuteilungs-, Aus&uuml;bungs- und Verfallsbedingungen fest. Sie k&ouml;nnen insbesondere vorsehen, dass aufgrund des Eintritts im Voraus bestimmter Ereignisse, wie eines Kontrollwechsels oder der Beendigung des Arbeits- oder Mandatsverh&auml;ltnisses, Vesting-, Aus&uuml;bungs- und Verfallsbedingungen weitergelten, verk&uuml;rzt oder aufgehoben werden, Verg&uuml;tungen unter der Annahme der Erreichung von Zielwerten ausgerichtet werden oder Verg&uuml;tungen verfallen. Die Gesellschaft kann die erforderlichen Aktien auf dem Markt erwerben, aus Best&auml;nden eigener Aktien entnehmen oder unter Verwendung von bedingtem oder genehmigtem Kapital bereitstellen.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">35</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">shares or by using contingent or authorized share capital.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Subject to the approval by the General Meeting, the members of the Board of Directors may receive remuneration in cash at customary conditions for advisory services rendered outside their capacity as Board member for the benefit of the Company or companies under its control. The General Meeting may approve an additional bonus for the members of the Board of Directors in exceptional cases.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Vorbeh&auml;ltlich der Genehmigung durch die Generalversammlung, kann den Mitgliedern des Verwaltungsrats eine Entsch&auml;digung in bar zu markt&uuml;blichen Konditionen f&uuml;r Beratungst&auml;tigkeiten, welche diese ausserhalb ihrer Funktion als Verwaltungsratsmitglied und zu Gunsten der Gesellschaft oder von ihr kontrollierter Gesellschaften erbringen, ausbezahlt werden. Die Generalversammlung kann in Ausnahmef&auml;llen einen zus&auml;tzlichen Bonus zu Gunsten der Verwaltungsratsmitglieder genehmigen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The compensation may also be paid for activities in companies that are directly or indirectly controlled by the Company and may be paid by the Company or by a company controlled by it.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Verg&uuml;tung kann auch ausgerichtet werden f&uuml;r T&auml;tigkeiten in Unternehmen, die durch die Gesellschaft direkt oder indirekt kontrolliert werden und kann durch die Gesellschaft oder durch von ihr kontrollierte Unternehmen ausgerichtet werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 35	Principles of the Compensation of the Executive Committee</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The compensation payable to the members of the Executive Committee is subject to the approval by the General Meeting and comprises the following elements:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a fixed remuneration payable in cash;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a performance-related remuneration payable in cash (variable); </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">a number of options, shares or equity-lined instruments in the Company (variable), as further outlined in article 43 of the articles of association.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 35	Grunds&auml;tze der Verg&uuml;tung f&uuml;r die Mitglieder der Gesch&auml;ftsleitung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Verg&uuml;tung f&uuml;r die Mitglieder der Gesch&auml;ftsleitung ist von der Generalversammlung zu genehmigen und umfasst folgende Elemente:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine fixe Verg&uuml;tung in bar;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine erfolgsabh&auml;ngige Verg&uuml;tung in bar (variabel); <br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eine Anzahl Optionen, Aktien oder anderen eigenkapitalbasierten Instrumenten der Gesellschaft (variabel), gem&auml;ss Artikel 43 der Statuten.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The performance-related remuneration depends on the Company's business success and the individual performance of the member of the Executive Committee based on the achievement of pre-determined targets during a business year. The Board of Directors determines annually at the beginning of each relevant</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die erfolgsabh&auml;ngige Verg&uuml;tung richtet sich nach dem Gesch&auml;ftserfolg und der individuellen Leistung gemessen nach dem Erreichen bestimmter vordefinierter Ziele &uuml;ber ein Gesch&auml;ftsjahr. Der Verwaltungsrat definiert j&auml;hrlich am Anfang jeder Leistungsperiode auf Antrag des Verg&uuml;tungsausschusses hin die relevanten Ziele und deren Gewichtung. Die H&ouml;he der erfolgsabh&auml;ngigen</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">36</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">business year the decisive targets and their weighting upon proposal by the Compensation Committee. The amount of the performance-related remuneration in cash for each member of the Compensation Committee is determined by the Board of Directors and may not exceed 100% of the respective individual fixed remuneration for the same year.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Verg&uuml;tung in bar f&uuml;r das jeweilige Gesch&auml;ftsleitungsmitglied wird vom Verwaltungsrat festgelegt und darf 100% der im entsprechenden Gesch&auml;ftsjahr relevanten individuellen, fixen Verg&uuml;tung nicht &uuml;berschreiten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The compensation may also be paid for activities in companies that are directly or indirectly controlled by the Company and may be paid by the Company or by a company controlled by it.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Verg&uuml;tung kann auch ausgerichtet werden f&uuml;r T&auml;tigkeiten in Unternehmen, die durch die Gesellschaft direkt oder indirekt kontrolliert werden und kann durch die Gesellschaft oder durch von ihr kontrollierte Unternehmen ausgerichtet werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 36	Compensation for new Members of the Executive Committee</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If new members of the Executive Committee are appointed and take up their position in the Company after the General Meeting has approved the maximum total compensation for members of the Executive Committee for the year in question, the new members may be paid an additional amount for the period until the next Ordinary Meeting of Shareholder. The additional amount payable to all new members of the Executive Committee may not exceed 50% of the respective total compensation already approved by the General Meeting. The additional compensation may only be paid if the total compensation amount that has been approved by the General Meeting for the compensation of the members of the Executive Committee is insufficient to compensate the newly appointed members. The General Meeting is not required to vote on this additional amount.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 36	Verg&uuml;tungen f&uuml;r neue Mitglieder der Gesch&auml;ftsleitung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Sofern neue Mitglieder der Gesch&auml;ftsleitung ernannt werden und ihre Stelle antreten, nachdem die Generalversammlung die Gesamtverg&uuml;tung f&uuml;r die Gesch&auml;ftsleitungsmitglieder im entsprechenden Jahr genehmigt hat, darf diesen neuen Mitglieder ein zus&auml;tzlicher Betrag f&uuml;r die Dauer bis zur n&auml;chsten ordentlichen Generalversammlung verg&uuml;tet werden. Dieser Zusatzbetrag an alle neuen Mitglieder der Gesch&auml;ftsleitung darf 50% der von der Generalversammlung f&uuml;r das betreffende Jahr bereits genehmigten Gesamtverg&uuml;tung nicht &uuml;bersteigen. Der Zusatzbetrag darf nur ausgerichtet werden, sofern und soweit die von der Generalversammlung beschlossenen Verg&uuml;tungsbetr&auml;ge an die Gesch&auml;ftsleitungsmitglieder bis zur n&auml;chsten ordentlichen Generalversammlung f&uuml;r die Verg&uuml;tung der neuen Mitglieder nicht ausreicht. &Uuml;ber den verwendeten Zusatzbetrag stimmt die Generalversammlung nicht ab.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">This additional overall compensation is understood to include any settlements for any disadvantage suffered as a result of the change of job.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mit diesem Zusatzbetrag sind allf&auml;llige durch ein Gesch&auml;ftsleitungsmitglied erlittene Nachteile aufgrund Stellenwechsel abgegolten.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">37</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 37	Expenses</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Expenses which are not covered by the lump sum compensation pursuant to the Company's expense regulations shall be reimbursed following presentation of the supporting receipts. This additional remuneration is not subject to a separate vote by the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 37	Spesen</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Spesen, welche nicht durch die pauschale Spesenentsch&auml;digung gem&auml;ss Spesenreglement abgedeckt sind, werden nach Vorlage der entsprechenden Belege r&uuml;ckverg&uuml;tet. Diese R&uuml;ckverg&uuml;tung ist von der Generalversammlung nicht zu genehmigen.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 38	Compensation Agreements</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Agreements on compensation with members of the Board of Directors may not exceed the term of maximal one year.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 38	Vertr&auml;ge &uuml;ber die Verg&uuml;tung</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Vertr&auml;ge, die den Verg&uuml;tungen f&uuml;r die Mitglieder des Verwaltungsrats zugrunde liegen, sind auf maximal ein Jahr befristet.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Employment agreements of the members of the Executive Committee are principally concluded for an indefinite period of time whereas a notice period may not exceed twelve months. If an employment agreement is concluded for a fixed term such term may not exceed one year.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Arbeitsvertr&auml;ge der Gesch&auml;ftsleitungsmitglieder sind grunds&auml;tzlich unbefristet, wobei die K&uuml;ndigungsfrist maximal zw&ouml;lf Monate betragen darf. Wird ein befristeter Vertrag abgeschlossen, so darf dieser die Dauer von ein Jahr nicht &uuml;berschreiten.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 39	Mandates of a Member of the Board of Directors outside the Company</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">A member of the Board of Directors may cumulatively assume not more than the following number of mandates in the board of directors, the superior management or an administrative body of a legal entity which is obliged to be registered in the Swiss commercial register or an equivalent foreign register:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">7 mandates for publicly traded companies pursuant to article 727 para. 1 number 1 CO; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">8 mandates for companies pursuant to article 727 para. 1 number 2 CO; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5 mandates for companies which do not fulfil the criteria under a) and b) hereunder.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 39	Mandate eines Verwaltungsratsmitglieds ausserhalb der Gesellschaft</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ein Mitglied des Verwaltungsrats darf kumulativ maximal folgende Mandate in einem obersten Leitungs- oder Verwaltungsorgan von Rechtseinheiten, die verpflichtet sind, sich ins Handelsregister oder in ein entsprechendes ausl&auml;ndisches Register eintragen zu lassen, &uuml;bernehmen:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">7 Mandate f&uuml;r Publikumsgesellschaften gem&auml;ss Artikel 727 Abs. 1 Ziff. 1 OR; und</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">8 Mandate f&uuml;r Gesellschaften gem&auml;ss Artikel 727 Abs. 1 Ziff. 2 OR; und</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5 Mandate f&uuml;r Rechtseinheiten, welche die Kriterien gem&auml;ss lit. a) und b) hiervor nicht erf&uuml;llen.</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">38</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandates held in several legal entities each operating under the same management or same beneficial owner (group) are deemed to be a single mandate.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandate von verschiedenen Rechtseinheiten, welche aber derselben F&uuml;hrung oder derselben wirtschaftlichen Eigent&uuml;merin unterstehen (Konzern), gelten als ein Mandat, d&uuml;rfen aber insgesamt vierzig nicht &uuml;bersteigen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If a legal entity fulfills several of the above mentioned criteria, it can be freely counted towards any category. The following mandates are excepted from this restrictions:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">mandates in legal entities which are controlled by the Company or which control the Company;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">honorary mandates in charitable legal entities.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erf&uuml;llt eine Rechtseinheit mehrere der vorgenannten Kriterien, kann sie beliebig jeder auf sie zutreffenden Kategorie zugerechnet werden. Folgende Mandate sind von diesen Beschr&auml;nkungen ausgenommen:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandate in Rechtseinheiten, welche von der Gesellschaft kontrolliert werden oder welche die Gesellschaft kontrollieren;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ehrenamtliche Mandate in gemeinn&uuml;tzigen Rechtseinheiten.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.75pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.75pt;padding-left:67.75pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 40	Mandates of a Member of the Executive Committee outside the Company</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Each member of the Executive Committee may, with approval of the Board of Directors, cumulatively assume not more than the following number of mandates in the board of directors, the superior management or an administrative body of a legal entity which is obliged to be registered in the Swiss commercial register or an equivalent foreign register:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">2 mandates for publicly traded companies pursuant to article 727 para. 1 number 1 CO; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">3 mandates for companies pursuant to article 727 para. 1 number 2 CO; and</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5 mandates for companies which do not fulfil the criteria under litera a) and b) hereunder.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 40	Mandate eines Gesch&auml;ftsleitungsmitglieds ausserhalb der Gesellschaft<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jedes Mitglied der Gesch&auml;ftsleitung darf mit Genehmigung des Verwaltungsrats kumulativ maximal folgende Mandate in einem obersten Leitungs- oder Verwaltungsorgan von Rechtseinheiten, die verpflichtet sind, sich ins Handelsregister oder in ein entsprechendes ausl&auml;ndisches Register eintragen zu lassen, &uuml;bernehmen:</font></p><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">2 Mandate f&uuml;r Publikumsgesellschaften gem&auml;ss Artikel 727 Abs. 1 Ziff. 1 OR; und</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">3 Mandate f&uuml;r Gesellschaften gem&auml;ss Artikel 727 Abs. 1 Ziff. 2 OR; und</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5 Mandate f&uuml;r Rechtseinheiten, welche die Kriterien gem&auml;ss lit. a) und b) hiervor nicht erf&uuml;llen.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandates held in several legal entities each operating under the same management or same beneficial owner</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandate von verschiedenen Rechtseinheiten, welche aber derselben F&uuml;hrung oder derselben</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">39</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">(group) are deemed to be a single mandate.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">wirtschaftlichen Eigent&uuml;merin unterstehen (Konzern), gelten als ein Mandat.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If a legal entity fulfills several of the above mentioned criteria, it can be freely counted towards any category. The following mandates are excepted from this restrictions:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">mandates in legal entities which are controlled by the Company or which control the Company;	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">honorary mandates in charitable legal entities.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Erf&uuml;llt eine Rechtseinheit mehrere der vorgenannten Kriterien, kann sie beliebig jeder auf sie zutreffenden Kategorie zugerechnet werden. Folgende Mandate sind von diesen Beschr&auml;nkungen ausgenommen:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mandate in Rechtseinheiten, welche von der Gesellschaft kontrolliert werden oder welche die Gesellschaft kontrollieren;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ehrenamtliche Mandate in gemeinn&uuml;tzigen Rechtseinheiten.</font></div></div></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 41	Loans and Credits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The members of the Board of Directors and the Executive Committee may not be granted any loans, credits or securities. Excepted from the above are advances in the maximum amount of CHF 500'000 per person for attorneys' fees, court and other similar costs required for the defence of third-party liability claims permitted by article 31.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 41	Darlehen und Kredite</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Den Mitgliedern des Verwaltungsrats und der Gesch&auml;ftsleitung d&uuml;rfen keine Darlehen, Kredite oder Sicherheiten gew&auml;hrt werden. Ausnahme davon bilden Vorschusszahlungen &uuml;ber einen Betrag von maximal CHF 500'000 pro Person f&uuml;r Anwalts-, Gerichts- und &auml;hnliche Kosten zur Abwehr von Verantwortlichkeitsanspr&uuml;chen, sofern zul&auml;ssig nach Artikel 31.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 42	Pension Funds</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company shall remunerate members of the Board of Directors only in respect of the employer's mandatory contributions to social insurance. Above and beyond this, the Company shall not make any contributions to pension funds or other such pension plans. In exceptional cases, contributions such as these may be made subject to a request by the Compensation Committee and the approval of the General Meeting.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 42	Pensionskasse</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft leistet f&uuml;r die Mitglieder des Verwaltungsrats die gesetzlichen Arbeitgebersozialversicherungsbeitr&auml;ge. Abgesehen davon richtet die Gesellschaft keine Beitr&auml;ge an die Pensionskasse oder andere Vorsorgeeinrichtungen f&uuml;r die Mitglieder des Verwaltungsrats aus. Solche Beitr&auml;ge k&ouml;nnen ausnahmsweise auf Antrag des Verg&uuml;tungsausschusses und nach Genehmigung der Generalversammlung ausgerichtet werden.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Members of the Executive Committee participate in the Company's pension plans (the Company's pension fund and the management pension plan). The pension plans conform to the legal requirements (BVG). For members of the Executive Committee, the insured income</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Mitglieder der Gesch&auml;ftsleitung partizipieren am Pensionsplan der Gesellschaft (Pensionskasse sowie Management Pensionsplan). Der Pensionsplan hat den gesetzlichen Bestimmungen (BVG) zu entsprechen. Das versicherte Einkommen der Mitglieder der Gesch&auml;ftsleitung entspricht jeweils dem Betrag der fixen Verg&uuml;tung zuz&uuml;glich 50% der</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">40</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">is defined as the fixed remuneration plus 50% of the target performance-related remuneration, up to the legal maximum. Equity-linked income components are not included.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">erfolgsabh&auml;ngigen Verg&uuml;tung bis zum gesetzlichen Maximum. Aktienbezogene Verg&uuml;tungen werden nicht ber&uuml;cksichtigt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Within the overall compensation approved by the General Meeting, the Company may make additional payments into the Company's pension funds for the benefit of members of the Executive Committee in order to cover any disadvantage suffered as a result of the change of jobs or to purchase additional pension entitlements. In this context the Company may conclude life insurance policies on behalf of members of the Executive Committee and pay the insurance premiums either fully or in part.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann zugunsten der Gesch&auml;ftsleitungsmitglieder und im Rahmen der von der Generalversammlung genehmigten Gesamtverg&uuml;tungen zus&auml;tzliche Eink&auml;ufe in die Pensionskasse t&auml;tigen, um Nachteile aufgrund von Stellenwechsel auszugleichen oder zugunsten zus&auml;tzlicher Rentenanspr&uuml;che. In diesem Zusammenhang kann die Gesellschaft Lebensversicherungen zugunsten der Mitglieder der Gesch&auml;ftsleitung abschliessen und die Versicherungspr&auml;mien vollumf&auml;nglich oder teilweise zahlen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Upon retirement, the Company may also grant members of the Executive Committee a bridging pension to cover the period between early retirement at 62 and the ordinary age of retirement, if such bridging pension does not exceed 100% of the total annual compensation of the respective member last paid.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann ihren Gesch&auml;ftsleitungsmitgliedern eine &Uuml;berbr&uuml;ckungsrente zusichern, um die Zeitdauer zwischen einer Fr&uuml;hpensionierung ab dem 62. Altersjahr und dem ordentlichen Pensionsalter abzudecken, soweit eine solche &Uuml;berbr&uuml;ckungsrente 100% der letztmalig an dieses Mitglied bezahlte Jahresverg&uuml;tung nicht &uuml;bersteigt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 43	Option and Share Plans</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Under the Company's Option Plan, the Board of Directors, upon proposal of the Compensation Committee, allocates the participating members of the Executive Committee and the Board of Directors a fixed number of options, shares or other equity-linked instruments with a vesting for a period to be determined by the Board of Directors (the vesting period). At the end of the vesting period, participants in the Option Plan are entitled to exercise the options granted against payment of the strike price. These options to acquire shares in the Company or allocated shares or other equity-linked instruments are subject to the basic principles set out in the following:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 43	Options- und Aktienpl&auml;ne</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Gem&auml;ss dem Optionsplan der Gesellschaft, teilt der Verwaltungsrat auf Antrag des Verg&uuml;tungsausschusses den Mitgliedern der Gesch&auml;ftsleitung und des Verwaltungsrats eine bestimmte Anzahl Optionen, Aktien oder anderen eigenkapitalbasierten Instrumenten zu, welche einer durch den Verwaltungsrat festzulegenden Sperrfrist unterliegen. Am Optionsplan partizipierende Mitglieder sind nach Ablauf der Sperrfrist berechtigt, die gew&auml;hrten Optionen gegen Bezahlung des Aus&uuml;bungspreises auszu&uuml;ben. Die Optionen, welche zum Erwerb von Aktien an der Gesellschaft berechtigen, bzw. zugeteilten Aktien oder anderen eigenkapitalbasierten Instrumenten unterliegen den folgenden Grunds&auml;tzen:</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Es liegt im freien Ermessen des Verwaltungsrats, ob und wem Optionen, Aktien oder anderen </font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">41</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">it is the sole discretion of the Board of Directors to decide whether to allocate options, shares and other equity-linked instruments and to whom;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">each year, the Board of Directors, upon proposal of the Compensation Committee, stipulates the number of options and shares to be allocated, the date of allocation and the strike price;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">each option incorporates a non-transferable, pre-emptive, and contingent right to acquire a certain number of Company's shares;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">in the case of a change of control (as defined in the Option Plan) or delisting of the Company's shares, the Board may decide that the vesting period shall end (accelerated vesting) and whether the participating member of the Executive Committee or the Board shall be entitled to exercise the options on a pro rata basis on the day the transaction that led to the change of control or delisting was executed. It is at the sole discretion of the Board of Directors to decide upon proposal of the Compensation Committee whether the objectives have been met; 	<br><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the individual members of the Executive Committee or the Board of Directors participating in the Option Plan are responsible for paying any taxes or social security contributions for which they are legally liable and for declaring income correctly to the authorities; 	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">it is at the sole discretion of the Board of Directors to decide whether to </font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:25.2pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.30000000000000004in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">eigenkapitalbasierten Instrumenten zugeteilt werden;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat bestimmt j&auml;hrlich auf Antrag des Verg&uuml;tungsausschusses Anzahl und Datum der Zuteilung sowie Aus&uuml;bungspreis der Optionen und Aktien;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Jede Option begr&uuml;ndet ein un&uuml;bertragbares, bedingtes Bezugsrecht eine bestimmte Anzahl Aktien der Gesellschaft zu erwerben;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Im Falle eines Kontrollwechsels (gem&auml;ss Definition im Optionsplan) oder der Dekotierung der Aktien kann der Verwaltungsrat entscheiden, ob die  Sperrfrist vorzeitig endet und das teilnehmende Gesch&auml;ftsleitungsmitglied oder Mitglied des Verwaltungsrat entsprechend berechtigt wird, seine Optionen pro-rata basierend auf dem Stichtag der Transaktion, welche zum Kontrollwechsel gef&uuml;hrt hat, oder der Dekotierung der Aktien auszu&uuml;ben. Der Verwaltungsrat entscheidet nach freiem Ermessen und auf Antrag des Verg&uuml;tungsausschusses, ob die Ziele in diesem Zusammenhang gegeben sind; </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das jeweilige Mitglied der Gesch&auml;ftsleitung oder des Verwaltungsrats, welches am Optionsplan teilnimmt, ist selber daf&uuml;r verantwortlich, dass die vom Empf&auml;nger zu bezahlenden Steuern oder Sozialabgaben bezahlt und Einkommen der zust&auml;ndigen Beh&ouml;rden korrekt gemeldet werden.</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat entscheidet nach freiem Ermessen &uuml;ber Erg&auml;nzungen des Optionsplans im Rahmen der obgenannten Grunds&auml;tze oder &uuml;ber dessen Beendigung.</font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">42</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:21.6pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.35in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.667%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">supplement the Option Plan within the bounds of the principles set out above or to discontinue it.</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Company may periodically offer shares in the Company to important and long-term employees for a price being at maximum 10% below the average volume-weighted price of the last 30 trading days at the stock exchange. Members of the Board of Directors and the Executive Committee may be included in this programme. The shares acquired thereby shall be blocked for a period of at least 3 years.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft kann periodisch Aktien der Gesellschaft zu einem Preis, der maximal 10% unter dem &uuml;ber 30 B&ouml;rsentage volumengewichteten durchschnittlichen Kurs an der B&ouml;rse liegt, an wichtige und langj&auml;hrige Mitarbeiter abgeben. Die Mitglieder des Verwaltungsrats und der Gesch&auml;ftsleitung k&ouml;nnen in dieses Programm eingeschlossen werden. Die so erworbenen Aktien sind f&uuml;r mindestens 3 Jahre gesperrt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.4pt;padding-left:39.4pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">VIII.	Fiscal Year, Accounting principles, Allocation of Profits</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">VIII.	Gesch&auml;ftsjahr, REchnungslegung, Gewinnverteilung</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 44	Fiscal Year</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Board of Directors shall determine the start and the end of the Company's business year.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 44	Gesch&auml;ftsjahr</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Der Verwaltungsrat bestimmt, wann das Gesch&auml;ftsjahr beginnt und wann es endet.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 45	Accounting</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The annual accounts consist of the profit and loss statement, the balance sheet, the cash flow statement, the annex and the management report, and shall be drawn up pursuant to the provisions of the Swiss Code of Obligations, particularly of articles 958 et seq. CO, and the generally accepted commercial principles and customary rules in that business area.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 45	Rechnungslegung</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Jahresrechnung besteht aus der Erfolgsrechnung, der Bilanz, der Geldflussrechnung, dem Anhang und dem Lagebericht und ist gem&auml;ss den Vorschriften des Schweizerischen Obligationenrechts, insbesondere Artikeln 958 ff. OR, sowie nach den allgemein anerkannten kaufm&auml;nnischen und branchen&uuml;blichen Grunds&auml;tzen zu erstellen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">If required by law, the consolidated financial statements shall be drawn in accordance with the provisions of article 962 CO.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Konzernrechnung wird, sofern gesetzlich vorgeschrieben, gem&auml;ss den Bestimmungen von Artikeln 962 OR erstellt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 46	Allocation of Profits</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Subject to the legal provisions regarding distribution of profits, the profit as shown on the balance sheet shall be allocated by</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 46	Gewinnverteilung</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Generalversammlung beschliesst nach Entgegennahme der Antr&auml;ge des Verwaltungsrates und des Berichtes der Revisionsstelle unter Vorbehalt</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">43</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">the General Meeting at its discretion after receipt of the proposals of the Board of Directors and the Auditors.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">der gesetzlichen Bestimmungen &uuml;ber die Verwendung des Bilanzgewinnes und setzt die Dividende und den Zeitpunkt ihrer Auszahlung fest.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">In addition to the legal reserves, the General Meeting may create supplemental reserves.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zus&auml;tzlich zu den gesetzlichen Reserven kann die Generalversammlung zus&auml;tzliche Reserven bereitstellen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Dividends not claimed within five years after the due date shall remain with the Company and be allocated to the general reserves.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Dividenden, die nicht innerhalb von f&uuml;nf Jahren nach dem F&auml;lligkeitstag beansprucht werden, verbleiben bei der Gesellschaft und werden den allgemeinen R&uuml;cklagen zugef&uuml;hrt.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Ix.	Dissolution and Liquidation</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">ix.	Aufl&ouml;sung und Liquidation</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 47	Dissolution and Liquidation</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The dissolution and liquidation of the Company shall take place in accordance with the provisions of the Swiss Code of Obligations.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 47	Aufl&ouml;sung und Liquidation</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">F&uuml;r die Aufl&ouml;sung und Liquidation der Gesellschaft gelten die Bestimmungen des Schweizerischen Obligationenrechts.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">X.	Notices and Publications</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">X.	Mitteilungen und Bekanntmachungen</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Article 48	Notices and Publications</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">The Swiss Official Gazette of Commerce (SOGC) is the official publication medium.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 48	Mitteilungen und Bekanntmachungen</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Das Schweizerische Handelsamtsblatt (SHAB) ist das offizielle Publikationsmedium.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Shareholder communications and notices the shareholders shall be made by publication in the Swiss Official Gazette of Commerce or sent by mail or e-mail to the addresses registered in the share register.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Mitteilungen und Bekanntmachungen an die Aktion&auml;re erfolgen durch Publikation im Schweizerischen Handelsamtsblatt oder durch Brief oder E-Mail an die im Aktienbuch verzeichneten Adressen.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Unless the law provides otherwise, notices shall be given to creditors by publication in the Swiss Official Gazette of Commerce. The Board of Directors may assign further means of communication.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Bekanntmachungen an die Gl&auml;ubiger erfolgen in den vom Gesetz vorgeschriebenen F&auml;llen durch Ver&ouml;ffentlichung im Schweizerischen Handelsamtsblatt, dem Publikationsorgan der Gesellschaft. Der Verwaltungsrat kann weitere Publikationsmittel bezeichnen.</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">44</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">XI.	QUALIFIED FACTS</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:39.5pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-39.5pt;padding-left:39.5pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">XI.	QUALIFIZIERTE TATBEST&Auml;NDE</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 49	Contribution in Kind</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">In connection with the capital increase of 1 March 2023, and in accordance with the contribution in kind agreement as of 1 March 2023 (the Contribution in Kind Agreement), the Company acquires 10'489'371 ordinary shares in the nominal amount of UDS 0.001 each of European Biotech Acquisition Corp with registered seat in George Town, Cayman Islands (EBAC), from Continental Stock Exchange Corp (Contributor), acting in its own name but on behalf of the shareholders of EBAC. The shares of EBAC are acquired for a total value of USD 104'893'710.00. Based on the Contribution in Kind Agreement and as consideration, the Company issues to the Contributor, acting in its own name but for the account of the holders of ordinary shares of EBAC, a total of 10'489'371 fully paid registered shares with a with a par value of CHF 0.01 each.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:67.85pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:-67.85pt;padding-left:67.85pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Artikel 49	Sacheinlage</font></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft &uuml;bernimmt bei der Kapitalerh&ouml;hung vom 1. M&auml;rz 2023 gem&auml;ss Sacheinlagevertrag vom 1. M&auml;rz 2023 (Sacheinlagevertrag) 10'489'371 Aktien (ordinary shares) im Nennwert von USD 0.001 der European Biotech Acquisition Corp, mit Sitz in George Town, Cayman Islands (EBAC), von Continental Stock Exchange Corp (Einlegerin), handelnd im eigenen Namen aber auf Rechnung der Aktion&auml;re der EBAC. Die Aktien der EBAC werden zu einem &Uuml;bernahmewert von insgesamt USD 104'893'710.00 &uuml;bernommen. Im Einklang mit dem Sacheinlagevertrag weist die Gesellschaft als Gegenleistung der Einlegerin, handelnd im eigenen Namen aber auf Rechnung der Aktion&auml;re der EBAC, insgesamt 10'489'371 voll einbezahlte Namenaktien mit einem Nennwert von je CHF 0.01 der Gesellschaft zu.</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#34;In connection with the capital increase of 2 March 2023, and in accordance with the contribution in kind agreement as of 2 March 2023 (the Contribution in Kind Agreement), the Company acquires</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">3'306'771 registered shares (Common Shares) with a nominal value of CHF 0.10 each;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">1'623'793 registered shares series A (Preferred Shares Series A) with a nominal value of CHF 0.10 each;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">2'486'188 registered shares series B1 (Preferred Shares Series B1) with a nominal value of CHF 0.10 each;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">1'675'474 registered shares series B2 (Preferred Shares Series B2 First Tranche) with a nominal value of CHF 0.10 each;</font></div></div></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Die Gesellschaft &uuml;bernimmt bei der Kapitalerh&ouml;hung vom 2. M&auml;rz 2023 gem&auml;ss Sacheinlagevertrag vom 2. M&auml;rz 2023 (Sacheinlagevertrag) 	 <br></font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">3'306'771 Namenaktien (Stammaktien) mit einem Nennwert von je CHF 0.10;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">1'623'793 Namenaktien (Vorzugsaktien Serie A) mit einem Nennwert von je CHF 0.10;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> 	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">2'486'188 Namenaktien (Vorzugsaktien Serie B1) mit einem Nennwert von je CHF 0.10;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"> 	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">1'675'474 Namenaktien (Vorzugsaktien Serie B2 erste Tranche) mit einem Nennwert von je CHF 0.10;<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">426'378 Namenaktien (Vorzugsaktien Serie B2 zweite Tranche) mit einem Nennwert von je CHF </font></div></div></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.28in;min-height:1.33in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Verdana',sans-serif;min-width:fit-content;">Exhibit 99.2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Verdana',sans-serif;min-width:fit-content;">45</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.81%;"></td>
    <td style="width:2.4%;"></td>
    <td style="width:48.79%;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="text-indent:14.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">426'378 registered shares series B2 (Preferred Shares Series B2 Second Tranche) with a nominal value of CHF 0.10 each; </font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">603'472 registered shares series B2 (Preferred Shares Series B2 Third Tranche) with a nominal value of CHF 0.10 each</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5'337'777 registered shares series C 1a (Preferred Shares Series C 1a First Tranche) with a nominal value of CHF 0.10 each</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">362'036 registered shares series C 1a (Preferred Shares Series C 1a Second Tranche) with a nominal value of CHF 0.10 each</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">197'745 registered shares series C 1b (Preferred Shares Series C 1b) with a nominal value of CHF 0.50 each</font></div></div><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">of Oculis SA with registered seat in Ecublens (VD), Switzerland, from Continental Stock Exchange Corp (Contributor), acting in its own name but on behalf of the shareholders Oculis SA. The shares of Oculis SA are acquired for a total value of USD 202'770.02 and CHF 37'939.95. Based on the Contribution in Kind Agreement and as consideration, the Company issues to the Contributor, acting in its own name but for the account of the shareholders of Oculis SA, a total of 24'070'997 fully paid registered shares with a with a par value of CHF 0.01.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:14.4pt;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;visibility:hidden;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">0.10; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">603'472 Namenaktien (Vorzugsaktien Serie B2 dritte Tranche) mit einem Nennwert von je CHF 0.10; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">5'337'777 Namenaktien (Vorzugsaktien Serie C 1a erste Tranche) mit einem Nennwert von je CHF 0.10;<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">362'036 Namenaktien (Vorzugsaktien Serie C 1a zweite Tranche) mit einem Nennwert von je CHF 0.10; sowie</font></div></div><div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.2in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">&#xf02d;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">197'745 Namenaktien (Vorzugsaktien Serie C 1b) mit einem Nennwert von je CHF 0.50</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">	<br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">&#160;</font></div></div><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri Light',sans-serif;min-width:fit-content;">der Oculis SA mit Sitz in Ecublens (VD), Schweiz, von Continental Stock Exchange Corp (Einlegerin), handelnd im eigenen Namen aber auf Rechnung der Aktion&auml;re der Oculis SA. Die Aktien der Oculis SA werden zu einem &Uuml;bernahmewert von insgesamt USD 202'770.02 und CHF 37'939.95 &uuml;bernommen. Im Einklang mit dem Sacheinlagevertrag weist die Gesellschaft als Gegenleistung der Einlegerin, handelnd im eigenen Namen aber auf Rechnung der Aktion&auml;re der Oculis SA, insgesamt 24'070'997 voll einbezahlte Namenaktien mit einem Nennwert von je CHF 0.01 zu.</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Verdana',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri Light',sans-serif;min-width:fit-content;">Zug, 29. Mai 2024</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img187686630_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img187686630_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "> =(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9\^_& C_ (25>?X:\X)KK?B'JB:GXIN7C?<B$J*Y$UZ$%:*/.F[R9Z9\&O\
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
